Stock Market Today 17.01.2026

Harvey Norman Holdings: ROE Near Industry, Earnings Slump Clouds Outlook (ASX: HVN)

January 17, 2026, 6:47 PM EST. Harvey Norman Holdings (ASX: HVN) has fallen 7.1% over three months as investors assess its fundamentals. The piece centers on ROE (return on equity), which stands at about 11% for the trailing twelve months to June 2025, with AU$526 million in net profit against AU$4.8 billion of shareholders' equity. While this sits near the industry average of ~10%, the five-year net income has declined 13%, suggesting a profitability/earnings decline challenge. By contrast, the industry posted about 6.3% earnings growth over the same period, widening the contrast and raising concerns about HVN's growth path. The company's payout ratio is 64% (retaining 36%), which tempers reinvestment. The report notes whether the market has priced in the future outlook, pointing to an intrinsic value infographic as part of the analysis.

Insider Buying Offsets 11% Selloff for Carbonxt Group (ASX:CG1)

January 17, 2026, 6:46 PM EST. Insiders bought AU$2.03 million of Carbonxt Group Limited (ASX:CG1) shares over the past 12 months, a stake now valued at AU$2.66 million after an 11% drop. While insider buying isn't a guarantee of performance, it signals alignment with shareholders. The largest purchase was Simon Maher's AU$1.2 million buy at AU$0.06 per share, well below the recent AU$0.086 level, so it offers limited read-through about current sentiment. There were no insider sales in the period. Insider ownership stands at about 24% of the stock, worth roughly AU$8.9 million. No transactions occurred in the last three months. Analysts at Simply Wall St flag two warnings for investors to weigh before trading, underscoring remaining risks.

History hints the S&P 500 could climb again in 2026

January 17, 2026, 6:30 PM EST. History offers a clear answer for 2026: the S&P 500 could keep rising, though risks loom. The index has climbed double digits for three straight years, up about 78% in that span, powered by AI growth stocks and a supportive, lower-rate environment that boosts corporate earnings and consumer spending. The market now trades near levels last seen in the dot-com era, as measured by the inflation-adjusted Shiller CAPE ratio, signaling valuation scrutiny ahead. Demand for AI products remains robust, with data-center firms expanding capacity and firms like Alphabet and Meta reporting steady earnings growth. If the AI cycle stays intact, the market may push higher again. But higher valuations, a potential shift in rates or policy and past tariffs headwinds could temper upside.

Teck Resources TECK.A:CA Long-Term Buy near 62.38, Stop at 62.07

January 17, 2026, 6:16 PM EST. TECK.A:CA, Teck Resources Ltd Class A, is covered for a long-term view with data dated Jan 17, 2026. Traders are advised to buy near 62.38, with a stop at 62.07 and no short plans at this time. The signals are AI-generated by Stock Traders Daily, with the timestamp noted. Ratings show Near-term: Strong, Mid-term: Weak, and Long-term: Weak. The plan provides no defined price target beyond the entry; risk control rests on the 62.07 stop. Readers should treat AI guidance as provisional and subject to market change.

Applied Digital elevates co-founder Jason Zhang to President

January 17, 2026, 6:15 PM EST. Applied Digital Corporation said on January 14, 2026 its board approved promoting co-founder and Chief Strategy Officer Jason Zhang to President and Co-Founder. The move formalizes his role in guiding strategy and growth as the company scales its AI infrastructure platform. Zhang, a former investor at Sequoia Capital and MSD Capital, has led leases for the Polaris Forge 1 and Polaris Forge 2 data center campuses in North Dakota and will continue to work with Wes Cummins, who remains chairman and CEO. The employment agreement was amended to set Zhang's annual base salary at $700,000. Analysts cited by Spark on APLD called the stock a Buy with a $41 price target, though Spark notes weak financial quality and elevated leverage. APLD designs and operates hyperscale data centers with a focus on AI and cloud workloads.

Abundant US nat-gas supplies pressuring prices

January 17, 2026, 6:01 PM EST. Feb Nymex natural gas (NGG26) settled down 0.8%, keeping pressure on prices after a three-month low. Abundant US supplies weigh on the market as the EIA reported inventories about 3.4% above the five-year seasonal average. Forecasters see colder-than-normal US temperatures for much of the January 21-30 period, which could lift heating demand. Pressure from weak LNG export feedgas at Corpus Christi and Freeport allows storage to build, a bearish factor. The EIA on Tuesday trimmed its 2026 dry gas production forecast to 107.4 bcf/d. On Friday, Lower-48 gas production was about 113.0 bcf/d, while demand ran around 104.9 bcf/d, per BNEF, and LNG net flows stood at about 19.8 bcf/d. Rigs declined to 122 in the week.

Lottery Corporation TLC: Individuals Own 51%, Institutions 48%; Top 25 Hold 46%

January 17, 2026, 6:00 PM EST. ASX-listed The Lottery Corporation Ltd (ASX:TLC) shows a broadly dispersed shareholder base. Individual investors own 51% and institutions (institutional investors such as pension funds and asset managers) hold 48%-a split that keeps significant retail sway alongside established funds. The top 25 shareholders control about 46% of the stock, indicating no single owner dominates. The largest single holder is AustralianSuper Pty Ltd with about 14% of shares. The spread suggests both public participation and institutional backing, with the caveat that large holders could move the price if they trade heavily. Insider ownership data aren't provided here. Analysts cover TLC and forecast growth, but the ownership mix is a separate lens on potential influence over corporate decisions.

Cencora expands credit facilities to back OneOncology deal

January 17, 2026, 5:49 PM EST. Cencora, Inc. expanded its liquidity toolkit to back the OneOncology acquisition. On January 12, 2026, the company amended its existing revolving credit agreement, boosting total commitments by $1.0 billion to $5.5 billion. It also secured a new senior unsecured multi-year term loan facility totaling $1.5 billion in two tranches and a separate $3.0 billion 364-day term loan, primarily to finance the acquisition, refinance OneOncology's debt, and cover fees. The facilities replace the previously arranged $4.5 billion bridge facility, signaling strong banker support with JPMorgan Chase, Citibank, Bank of America, Wells Fargo, BNP Paribas, Société Générale, and MUFG in lending, advisory, or securitization roles. Analysts have mixed views: a Buy at a $415 target for COR, and Spark rates the stock Neutral.

Amer Sports valuation: DCF signals overvaluation despite high P/E

January 17, 2026, 5:47 PM EST. Amer Sports (AS) traded at $37.03, down 3.9% in the past week. The stock has fallen 2.3% over 30 days and 1.3% year-to-date, while the 1-year return stands at 24.4%. Simply Wall St gives a valuation score of 1/6. The report uses a two-stage Free Cash Flow to Equity (FCF) model – cash available to equity holders after capital needs – with trailing FCF about $254.1 million; projections rise to $1,448.9 million by 2035, and interim years of $472.2 million (2026) and $655.0 million (2027). Discounting yields an intrinsic value of about $32.22 per share, implying the stock is roughly 14.9% overvalued at $37.03. The stock also trades at a P/E of 65.97x, signaling high earnings expectations baked into the price.

Axalta Coating Systems valuation after price move; fair value suggests upside

January 17, 2026, 5:46 PM EST.Axalta Coating Systems (AXTA) trades around US$33.57 after a period of mixed momentum. Over 90 days the stock rose about 17.95%, but the one-year total return shows a -7.47% decline, signaling a cooled initial optimism. A recent analysis puts a fair value of about US$36.87, implying an intrinsic discount near 49% and potential upside if earnings, margins and capital allocation improve. The thesis cites rising demand for advanced and sustainable coatings amid EV adoption, stricter VOC regulations, and product innovations such as NexJet. Risks include possible volume softness in core coatings and cost/synergy execution. Investors are reminded to weigh valuation against the forecast and to consider how a future earnings multiple may differ from today.

Sky Metals insiders rewarded as shares jump 32%, AU$29 million market cap rise

January 17, 2026, 5:45 PM EST. Sky Metals Limited (ASX: SKY) shares rose 32% last week, lifting market capitalization by about AU$29 million. Insiders who bought stock over the past year saw a strong gain: a three-person purchase totaling AU$578k is now worth AU$1.29 million, a ~123% gain on the initial stake. Executive Chairman Norman Seckold led the year-long buying with AU$520k of shares at around AU$0.065, well below the latest price of AU$0.14. The move suggests insider confidence, though it does not by itself indicate a valuation view. In the last 12 months, insiders bought but did not sell. Insider ownership sits near 17% (about AU$20 million). Sky Metals still reports losses, which keeps risk in focus, even as alignment with insiders could support a re-rating if losses narrow.

Three Vanguard ETFs to Weather a 2026 Recession

January 17, 2026, 5:33 PM EST. The article argues a recession could loom in 2026 even as benchmarks push higher. An MDRT December 2025 survey found about 80% of Americans worry about a downturn. It urges investors to stay invested and use ETFs to temper risk. The piece centers on three Vanguard funds. First, the Vanguard S&P 500 ETF (VOO) tracks the S&P 500, about 500 large-cap stocks, with a long record of weathering recessions. Capital Group data show the index has produced positive total returns in every 10-year stretch over the last 82 years. Holding VOO for a decade can damp volatility. The second is the Vanguard Total Stock Market ETF (VTI), spanning the entire US equity market with thousands of stocks for broad diversification. A third Vanguard fund rounds out the lineup.

Analysts lift Catalyst Metals forecast; 2026 revenue and EPS rise, price target raised

January 17, 2026, 5:32 PM EST. Analysts have upgraded near-term forecasts for Catalyst Metals (ASX:CYL), lifting revenue and EPS projections for 2026. The four-analyst consensus now sees AU$622 million in revenue for 2026, up 72% from the prior year, and AU$0.83 in statutory EPS, up 134%. The upgrade also lifts the price target to AU$12.16, about 16% higher than before. The stock has risen about 24% in the past week to AU$9.00. The revisions imply faster growth than the broader mining sector, which is expected to grow about 7.7% annually. Caution remains: earnings quality concerns are noted alongside the optimistic outlook.

Pro Medicus (ASX: PME) slides 3.5% this week as five-year returns track earnings growth

January 17, 2026, 5:31 PM EST. Pro Medicus Limited (ASX: PME) shares slid 3.5% this week as investors weigh long-term fundamentals against a steep run in the past five years. The stock is about 401% higher than five years ago, and total shareholder return over the period topped 410% on the back of dividends. Over five years, EPS grew about 38% annually, roughly matching the 38% annual rise in the share price, suggesting sentiment tracks fundamentals. Insider buying gained traction in the last three months. The broader market rose about 11% last year, but PME fell roughly 18% including dividends. For patient investors, the recent sell-off may present a potential entry point.

BCE looks undervalued after mixed returns; fair value CA$36.47 vs CA$33.59

January 17, 2026, 5:30 PM EST. BCE (TSX:BCE) trades at CA$33.59 amid a mixed return profile. A 1-month gain of 5.23% sits beside a 3-year TSR decline of 32.44%. A discounted cash flow framework yields a fair value of CA$36.47, signaling the stock is undervalued versus the current price. Analysts' targets span from CA$30.00 to CA$45.00, with a consensus CA$35.41. The narrative assumes revenue growth in the low single digits, stable margins, and a discount rate of 7.59%. Risks include regulatory limits on fiber buildout and high capital needs that could squeeze free cash flow and margins. The question for investors is whether valuation leaves room for upside or already prices in future growth. BCE revenue: CA$24.486 billion; net income: CA$6.172 billion.

Hawkins (HWKN) overvalued after multi-year rally, DCF fair value trails price

January 17, 2026, 5:29 PM EST. Hawkins (HWKN) trades around $152 after a multi-year rally, prompting questions about further upside. The stock's valuation screen gives a 1/6 score, with a DCF-based intrinsic value of about $98.23 per share-roughly 54.7% below the current price, i.e., overvalued on this method. The model uses a two-stage free cash flow to equity, with trailing FCF around $75.1 million and forecasts of $80.7 million in 2026, $97.0 million in 2028, and about $117.2 million by 2035. Short-term moves are mixed, yet the five-year run has been strong, fueling questions about growth prospects and risk. A quick P/E snapshot accompanies the DCF view as investors weigh sentiment against value.

Charles River Laboratories: DCF signals 12.5% undervaluation at $219.70

January 17, 2026, 5:28 PM EST. Charles River Laboratories International trades around $219.70. The stock delivered 34.4% in the last year; 30-day gains 12.1%; YTD 8.5%. Over 3 and 5 years, returns are negative (-9.7% and -21.6%). The company's gains reflect demand for contract research in drug discovery and preclinical work. A valuation review grades the stock 4/6. Using a DCF model with a 2-stage Free Cash Flow to Equity, it starts from about $497.2 million in trailing FCF and projects to $851.1 million in 2035. The resulting intrinsic value is about $251.07 per share. At roughly $219.70, the stock sits about 12.5% below the intrinsic value, implying it is undervalued on this metric.

Cotton futures fall on Friday as export pace trails five-year average

January 17, 2026, 5:18 PM EST.Cotton futures fell Friday, with most contracts down 15 to 30 points. The US dollar index was down about 343 points, while crude oil slid $1.64 a barrel. USDA Export Sales for 2024/25 stood at 4.213 million running bales sold or shipped, about 37% of the USDA projection and roughly 12 percentage points behind the five-year average pace. ICE cotton stocks were unchanged at 15,526 bales. The Cotlook A Index dropped 100 points to 78.45 cents per pound. The USDA Average World Price (AWP) for next week rose to 55.35 cents/lb, up 11 points. Quotes: Dec 24 at 67 (-15); Mar 25 at 68.49 (-23); May 25 at 69.76 (-28). On the date of publication, Alan Brugler had no positions.

Soybeans drift higher on Friday ahead of MLK Day holiday

January 17, 2026, 5:16 PM EST. Soybeans edged higher on Friday, reversing early weakness as the market digests export pace. The national average cash price rose to $9.85 1/2, while soymeal futures fell about 70 cents and soy oil slipped 20-25 points. Markets will be closed Monday for the Martin Luther King Jr. Day holiday. Export Sales show total soybean commitments at 30.637 MMT as of 1/8, about 25% below a year earlier and 71% of the USDA projection, with shipments at 17.984 MMT or 42% of the USDA estimate and well under the 60% average pace. Brazilian crops gained on the day after Safras boosted its projection by 0.52 MMT to 179.28 MMT. Front-months: Mar 26 at $10.55 1/4, nearby cash $9.85 1/2, May 26 $10.67, Jul 26 $10.79 1/4.

Soybeans rise on Friday as futures rebound; export pace and COT trim long

January 17, 2026, 5:15 PM EST. Friday soybeans posted 4-5 cent gains across most contracts, while March futures slipped 4.75 cents on the week. The cmdtyView Cash Bean price rose 5.25 cents to $9.87 1/4 per bushel. Soymeal futures gained 80 cents to a higher level, despite March posting a weekly drop of $13.70. Soy Oil futures fell 18 to 36 points, though the weekly move stayed up 292 points. Markets will be closed Monday for the Martin Luther King Jr. Day holiday and reopen Monday evening. The Commitment of Traders (COT) report shows speculators trimming net longs by 44,756 contracts to 12,961 as of 1/13. Export sales data show total commitments at 30.637 MMT as of 1/8, 25% below year-ago, 71% of USDA projection; shipments at 17.984 MMT, 42% of USDA estimate and below normal pace.

Lucid stock at $10 after reverse split amid tightening cash runway

January 17, 2026, 5:14 PM EST.Lucid Group trades around $10 as its cash runway tightens and scale remains elusive. The company stays in start-up mode, building manufacturing and sales infrastructure to compete with incumbents. In Q3 2025 it warned cash would fund operations through the first half of 2027. A reverse split in August 2025 lifted the price but did not fix the business; without the split, shares would trade well under $1. The stock has fallen about 49% since the split. Investors worry about losses, capital needs and the risk of delisting if funding stalls. All told, the article cautions that only the most aggressive investors should consider Lucid below about $11.

Vital Farms stock (VITL) mixed price action keeps undervaluation case intact

January 17, 2026, 5:13 PM EST. Vital Farms trades near US$29.49, with mixed price action: -1.9% in 7 days, -8.4% in 30 days, -1.1% YTD, but up 74.9% over 3 years and 19.3% over 5 years. Simply Wall St's valuation checklist scores 4/6 on valuation. A two-stage DCF model, which projects future cash flows and discounts them to today, yields intrinsic value around US$305.16 per share, implying roughly a 90% undervalued gap versus the current price. The model uses 12-month free cash flow around US$6.7 million, with projections to 2027 of US$103.17 million and to 2035 of US$781.09 million. The P/E ratio, or price-to-earnings (how many dollars investors pay per dollar of earnings), adds another lens, though normal levels vary with growth expectations.

Himax Technologies (HIMX) overvalued after rally; DCF fair value around $1.87 vs $8.59 price

January 17, 2026, 5:12 PM EST. Himax Technologies (HIMX) remains at $8.59, up 5.1% in the last week and 6.8% over 30 days. YTD is flat; 1-year return barely positive; 3- and 5-year gains in the low- to mid-30% range. The Simply Wall St review flags a mixed valuation, scoring 3 of 6. A two-stage Discounted Cash Flow (DCF) approach-valuing a company by discounting expected future cash flows-yields an intrinsic value of about $1.87 per share. With the current price more than four times that, the model flags the stock as overvalued-about 359% above fair value. In short, the price reflects optimism around Himax's role in semiconductors and display-driver tech, but the cash-flow-driven valuation suggests investors are paying a steep premium.

Banner (BANR) earnings view hinges on net interest margin as NPAs rise

January 17, 2026, 5:10 PM EST. Banner Corporation is seen posting a quarterly EPS of $1.46, about 10% higher year over year, with revenue near $170.27 million. Analysts expect improvements in net interest margin (NIM) – a bank's lending profitability – and the efficiency ratio, even as non-performing assets rise. The near-term narrative hinges on converting Banner's West Coast franchise into steadier earnings, with higher EPS and revenue helping, though rising CRE and construction exposure keep credit quality in focus. Banner's 2024-25 results showed higher net interest income and wider margins; the 2028 outlook calls for about $815.0 million in revenue and $228.9 million in earnings. Two fair-value estimates span $47.34-$73.40 per share, with roughly 13% upside; NPAs and CRE risk cap upside potential.

Cattle futures slide into long weekend; cash steady, feeders retreat

January 17, 2026, 5:09 PM EST. Live cattle futures closed Friday lower, with contracts down $3.90 to $4.50. The week saw February down $1.57. Cash trade centered around $233 per cwt in the South and $232-$235 in the North. Feeder cattle retreated, giving back most of the week's strength; the Friday session saw losses of $6.50 to $8.10. The CME Feeder Cattle Index rose 73 cents to $370.15 on Jan. 15. The market will be closed Monday for Martin Luther King Jr. Day. USDA APHIS reported several new New World Screwworm cases in Mexico, bringing active Tamaulipas cases to eight. CFTC data showed managed money added 6,555 contracts to net long in live cattle futures and options to 101,316 as of Jan. 13; feeder specs trimmed net long by 530 to 16,308. Weekly slaughter was estimated at 562,000 head, above last week but below last year.

Coffee futures slide as Brazil rain forecast weighs on arabica, robusta

January 17, 2026, 5:08 PM EST. March arabica (KCH26) settled down 0.78%, with March ICE robusta (RMH26) off 0.07%. Prices gave up an early advance as updated weather forecasts raised rain chances in Brazil's coffee belts next week. Minas Gerais, the largest area for arabica, received 26.5 mm of rain in the week ended Jan 9, about 29% of the historical average, according to Somar Meteorologia. ICE arabica inventories sat at a 1.75-year low of 398,645 bags on Nov 20, later rebounding to a 2.5-month high; robusta stocks rose from a 1-year low to 4,278 lots. Brazil's 2025 production is seen at 56.54 million bags (up 2.4%); Vietnam's 2025/26 output is projected higher, with exports rising sharply. The sector faces ample supplies, per ICO and FAS outlooks, with ending stocks dipping about 5.4% to 20.148 million bags.

Fund Short Covering Lifts Sugar Prices

January 17, 2026, 5:07 PM EST. March NY world sugar #11 rose 2.54% to trade higher, while March London ICE white sugar #5 gained 2.37%, as fund short covering ahead of a three-day weekend in the U.S. for Martin Luther King Jr. Day. The advance follows Thursday's declines to one-month and two-month lows. India's production data showed 2025/26 output up 21% y/y to 15.9 MMT through Jan. 15; Brazil's Center-South output through mid-Dec rose 0.9% to 40.158 MMT. Covrig Analytics lifted its 2025/26 global surplus estimate to 4.7 MMT, while projecting 1.4 MMT for 2026/27. ISMA raised India's 2025/26 production to 31 MMT, signaling potential higher exports; ISO maintains a 2025/26 global surplus amid broader supply.

Iran Tensions Support Crude Prices as US Expands Middle East Presence

January 17, 2026, 5:06 PM EST. Oil rose Friday as tensions in Iran supported crude prices despite a firmer dollar. February WTI (CLG26) settled up 0.25% and February RBOB (RBG26) up 0.08%. Geopolitical risk around Iran helped cap Thursday's selloff. The United States moved a carrier group into the Middle East, though prospects for an immediate strike appeared diminished. Short covering also lent support. With Iran, OPEC's fourth-largest producer (around 3 million bpd), disruption remains a risk if protests widen. Traders tracked tanker disruptions near the Caspian Pipeline Consortium and resilient China demand. OPEC+ signaled a pause on Q1-2026 hikes, while the IEA sees a global oil surplus of roughly 4.0 million bpd in 2026.

Dollar recovers on Trump Fed Chair speculation as data weighs rate-cut odds

January 17, 2026, 5:05 PM EST. The DXY rose 0.04% on Friday as markets priced in a potential Fed chair shift after President Trump signaled a decision soon. Hassett's perceived dovishness vs a hawkish alternative like Warsh kept the debate alive and could support the dollar if a hawk takes the helm. U.S. data offered mixed signals: Dec manufacturing production rose 0.2% and was revised higher to +0.3% for Nov, while the Jan NAHB housing market index fell to 37. The market is pricing about a 5% chance of a -25 bp rate cut at the FOMC meeting on Jan 27-28; a larger cut remains in view for 2026. The ECB stance, the BOJ policy path, and risk events kept the yen bid and USD/JPY down roughly 0.35%.

Cotton futures slide; December leads retreat as outside markets mix

January 17, 2026, 5:04 PM EST. Cotton futures posted declines across most contracts, with the December contract down 80 points on Friday. The move came as the dollar index fell and crude oil rose, providing some outside support in other sectors. Speculators trimmed risk, with CFTC data showing non-commercial net shorts shrinking by 12,969 contracts to 17,549. The Seam reported 868 online cash bale sales at 67.83 cents per pound. ICE cotton stocks were unchanged, leaving 265 bales certified. The Cotlook A Index slipped 90 points to 84.90 cents per pound. The USDA Adjusted World Price was raised 223 points to 61.06 cents per pound. Nearby contracts settled lower: Dec 24 at 72.72 cents, down 30; Mar 25 at 74.52, down 25; May 25 at 75.61, down 26.

Commerzbank valuation under scrutiny as DCF signals €67.97 fair value vs €34.95 price

January 17, 2026, 5:03 PM EST. Commerzbank shares hover around €34.95 as investors compare momentum with fundamentals. The bank reports €11,320 in revenue and €2,427 in net income, with a value score of 3. The 90-day price gain of 17.84% contrasts with a year-to-date decline of 3.98%, though the five-year TSR remains solid. Market implied near-term fair value sits at about €33.87, below the current price, while a DCF model on Simply Wall St delivers a fair value of €67.97, implying roughly a 48.6% gap. Ongoing restructuring, cost discipline, and digital transformation aim to push the cost/income ratio toward 50% by 2028, lifting margins if successful. Risks include possible delays in digital initiatives and higher regulatory costs. Investors face a valuation tug between value and growth narratives.

Arm Holdings Poised as a Top Growth Stock in 2026 Tech Rally

January 17, 2026, 5:02 PM EST. Arm Holdings has drawn renewed investor attention as tech shares ride a nascent rally in early 2026. The stock pulled back after a late-2025 surge, trading around $105.78 and down about 40% from its 52-week high. Arm Holdings designs and licenses processor architectures; it does not manufacture chips, earning revenue from licenses and royalties tied to its IP. Its technology powers smartphones, cars, data centers and other devices, and almost all smartphone processors rely on its architecture. Bulls argue AI semiconductor demand could sustain growth even as valuation remains a concern. The backdrop includes stronger AI infrastructure spending and double-digit capex growth by hyperscalers in 2026. A sustained AI cycle could lift Arm Holdings, but a softer tailwind caps upside.

Lean hog futures steady at midday as MLK holiday looms; CME index up 11 cents

January 17, 2026, 5:01 PM EST. Lean hog futures were nearly steady at midday, with nearby contracts within a dime of unchanged. The CME Lean Hog Index rose 11 cents on Jan. 13 to $80.50. Markets will be closed Monday for the Martin Luther King Jr. Day holiday. The USDA's national base hog price was not reported Friday morning due to light volume. The pork carcass cutout value advanced a dime to $93.70 per cwt, led by gains in the loin and belly primals. Estimated federally inspected hog slaughter for Thursday was 492,000 head, lifting the weekly tally to 1.973 million – 7,000 higher than last week and about 46,900 above the year-ago week.

Wheat futures rise on Friday as export data, MLK holiday loom

January 17, 2026, 5:00 PM EST. Wheat futures closed higher on Friday as the complex posted gains of 6 to 11 cents. Chicago SRW rose 8-9 cents; KC HRW up 10-11; MPLS spring up 6-7. Markets will be closed Monday for MLK Day and reopen Monday evening. Export data through Jan 8 show commitments at 20.392 MMT, up 15% year over year, or about 83% of USDA's export projection and just below the 85% average pace. Shipments total 15.465 MMT, 63% of USDA estimate and above the 59% average. A South Korean importer bought 92,300 MT of US wheat in Thursday's tender. Prices: CBOT Mar 26 at $5.19 1/4, May 26 at $5.30 1/4; KCBT Mar at $5.28, May at $5.39 1/4; MIAX Mar $5.69, May $5.80 1/2.

Cattle futures slide Friday as cash trade weak ahead of MLK Day

January 17, 2026, 4:59 PM EST.Live cattle futures are down $4.25 to $4.85 Friday. Cash trades in the north were $232-235. The Fed Cattle Exchange showed $232 on 298 of 974 head offered. Feeder cattle futures are lower, down about $7.15-$8.75 at midday, erasing earlier strength. The CME Feeder Cattle Index rose 27 cents to $369.42 on Jan. 13. Markets will be closed Monday for Martin Luther King Jr. Day. The APHIS update shows new cases of New World Screwworm in Mexico, including six in Tamaulipas; active cases up to eight. USDA Wholesale Boxed Beef prices were higher; the Choice-Select spread widened to $1.61. Slaughter week-to-date at 469,000, up 4,000 vs last week, but 15,813 below a year ago. Front-month quotes: Feb 26 Live Cattle 231.800, Apr 26 233.575, Jun 26 229.225; Feeder: Jan 26 361.250, Mar 26 355.900, Apr 26 354.300.

Wheat futures rally into long weekend as export data supports demand

January 17, 2026, 4:56 PM EST. Wheat futures rallied into the long weekend across the three markets. Chicago SRW rose 7-8 cents on Friday, with the March contract up about 0.75 cent. KC HRW front months gained 9-10 cents; March was down 3 cents on the week. MPLS spring wheat added 2-3 cents, March down 2.5 cents. Markets are closed Monday for MLK Day and reopen Monday evening. The CFTC Commitment of Traders shows managed money trimming 936 contracts from its net short in CBT wheat futures and options to 106,229 by Tuesday. As of Jan. 13, specs were net short KC wheat futures and options by 12,781, down 2,874 from the prior week. Export data through Jan. 8 put total wheat commitments at 20.392 MMT, up 15% YoY and 83% of USDA projection; shipments at 15.465 MMT, 63% of USDA estimate. A South Korean importer bought 92,300 MT in Thursday's tender.

Walmart stock ticks up as leadership reshuffle sets stage for CEO handover

January 17, 2026, 4:43 PM EST. Walmart shares rose 0.42% to $119.70 after a broad leadership shake-up as John Furner prepares to take the CEO helm Feb. 1. He will oversee a reorganization that creates roles for David Guggina (President/CEO, Walmart U.S.), Chris Nicholas (CEO, Walmart International) and Latriece Watkins (CEO, Sam's Club). Kathryn McLay will exit Walmart International by January end and depart April 30. The changes were disclosed in an amended 8-K filing with the SEC. An 8-K is a company-reporting form for material events. Furner's compensation includes a $1.5 million base salary, a one-time stock award around $10 million, and an estimated $17 million in annual equity in fiscal 2027. Nasdaq-100 index changes move Walmart into AstraZeneca's spot ahead of Tuesday's open; Walmart reports fiscal Q4 results Feb. 19.

WiseTech Global's CargoWise rollout and new pricing reshape investment narrative

January 17, 2026, 4:41 PM EST. Analysts have grown more positive on WiseTech Global as CargoWise rollout accelerates and the company tests a new per-transaction, Value Pack pricing model. The narrative centers on whether deeper adoption and a refreshed commercial approach will lift revenue mix while managing churn risk from pricing changes. Six months to December 31, 2024 reported revenue of US$381 million and net income of US$106.4 million, with a fully franked interim dividend of 6.7 cents per share; guidance was revised lower at the bottom end due to delays in Breakthrough Products. The bull case hinges on faster CargoWise expansion and a successful transition to per-transaction pricing, potentially lifting revenue toward US$2.0 billion and earnings to nearly US$487 million by 2028.

QCLN AI-Generated Signals: Buy near 15.93, stop 15.85

January 17, 2026, 4:25 PM EST. January 17, 2026 report on First Trust NASDAQ Clean Edge Green Energy ETF (QCLN:CA) shows AI-generated signals. The recommended long plan is to buy near 15.93 with a stop loss at 15.85; no short positions are offered. The piece notes updated AI-generated signals for QCLN:CA and lists Near, Mid, and Long-term ratings as Strong, Weak, and Neutral. It emphasizes checking the timestamp and chart for context. The tone remains factual and concise, delivering actionable points without speculation and in line with market-reporting rhythm.

SiriusPoint Valuation Under Scrutiny After Share-Price Softness, MGA Growth Outlook

January 17, 2026, 4:10 PM EST. SPNT closed at $20.00, down 1.9%. One-month returns are -8.9%, but 90-day gains reach +13.4% and 1-year TSR is +33.4%, signaling weaker near term momentum but solid longer-term gains. A value score of 3, an intrinsic discount of 6.6%, and a 25% gap to analysts support a potential upside to a fair value around $27.50. At current levels, valuation suggests the market may be pricing in part of a recovery. The stock's expanding MGA partnerships in international and London markets, plus a tendency to retain more net risk, could lift both fee-based and underwriting income as these relationships scale. Risks include underperforming MGA deals, reserve trends, and catastrophe losses. The P/E stands at 12.6x vs US insurance avg 12.8x, implying possible upside if sentiment improves.

Sugar climbs on fund short-covering ahead of MLK weekend; India, Brazil output weigh on outlook

January 17, 2026, 4:09 PM EST.Sugar prices rose as funds covered short bets ahead of a US three-day weekend for Martin Luther King Day. March NY sugar #11 (SBH26) gained 2.68%, and March London white sugar #5 (SWH26) rose 2.44%. The move followed Thursday's lows, and the weekly Commitment of Traders (COT) report showed funds expanding white sugar net longs by 4,544 to a record 48,203. Fundamental factors remain mixed. India's 2025/26 sugar output climbed about 21% year on year to 15.9 MMT, while Brazil's Center-South output through mid-December rose 0.9% to 40.158 MMT. Analysts see a global sugar surplus – Covrig pegged 2025/26 at 4.7 MMT and 2026/27 at 1.4 MMT – though expectations of smaller Brazilian supplies and India's export potential could support prices.

Hitachi stock flagged as overvalued after multi-year gains (TSE:6501)

January 17, 2026, 3:56 PM EST. Hitachi's stock (TSE:6501) closed at ¥5,204, with 7-day returns of 1.3% and 30-day gains of 4.9%; YTD around 2.7%, and about 42.4% over 1 year. The chart shows roughly four times higher price over 3 years, and big gains over 5 years. Simply Wall St scores it 1/6 on undervaluation. Its DCF analysis-using a 2-stage Free Cash Flow to Equity model-yields an intrinsic value of ¥3,591.03 per share, about 44.9% below the current price, signaling OVERVALUED. The stock also trades at a P/E of 29.52x. In short, the valuation backdrop does not fully justify the rally, though momentum remains.

Solventum (SOLV) valuation signals upside as momentum cools; fair value near $85.64

January 17, 2026, 3:55 PM EST. Solventum (SOLV) traded near $79.48, with a one-day gain of 1.19% and a week-long rise of 7.73%. Three-month return stands at 10.14%, while the one-year total shareholder return is 8.12%, suggesting momentum has cooled but not erased. A base case from Simply Wall St shows a fair value around $85.64, implying a ~40% discount to intrinsic value or a modest valuation gap. The stock carries a value score of 5 and a proposed price target about 10% higher. The company's pipeline-Negative Pressure Wound Therapy, advanced wound care, sterilization, and digital health solutions such as autonomous coding-could support long-term top-line and earnings growth amid rising demand for healthcare tech. Risks include the 3M separation, ERP rollout, and SKU rationalization that could weigh on reported growth and margins.

IGO's momentum and webcast plan shape investment narrative in battery minerals era

January 17, 2026, 3:53 PM EST. IGO Ltd's stock has strengthened on ASX technical uptrend signals as the miner gears up for a late-January webcast to review December 2025 results. Lithium prices have fallen and supply appears stabilizing, but investors are focusing more on IGO's role in the battery minerals sector and upcoming disclosures. The market sees momentum in lithium-related equities as a short-term catalyst, even as IGO remains loss-making with forecast revenue contraction and no interim dividend. The webcast is expected to frame cash flows, production guidance and capital allocation following a A$954.6 million loss. Ausbil exited as a substantial holder, reducing but not changing the core risk that valuation relies on future earnings recovery. Near-term funding and earnings risk remains.

Nutanix appears undervalued after price slump, DCF suggests

January 17, 2026, 3:39 PM EST. Nutanix Inc. NTNX closed at $45.74, after a 7-day decline of 14.5% and a year-to-date drop of 9.6%. Seven days aside, three- and five-year returns run 70.7% and 36.5%, but the stock is down 29.8% over the last 12 months. The shares carry a valuation score of 3 out of 6, signaling mixed sentiment about cloud-infrastructure software and subscription models. A two-stage Free Cash Flow to Equity (FCF; cash available to equity holders) model yields an intrinsic value of about $74.61 per share, suggesting ~38.7% undervaluation versus the current price. The model is anchored by a trailing twelve-month FCF of about $773.8 million and projects roughly $1.55 billion in 2035, underscoring the sector's sensitivity to subscription dynamics.

Halliburton Valued After 17% Rally, DCF Indicates Undervaluation

January 17, 2026, 3:38 PM EST.Halliburton (HAL) closed at $32.57 after a 17.4% 30-day rally, with a 12.2% return over the last year. A valuation check scores 4 of 6, showing several signals of potential undervalued status alongside some balanced factors. Using a two-stage Free Cash Flow to Equity model, the latest DCF yields an intrinsic value of about $72.06 per share, implying roughly a 54.8% discount to the current price. That view brands HAL as undervalued on cash-flow grounds. A traditional P/E multiple around 20.9x anchors the earnings argument, placing the stock near energy-services peers. The analysis also links broader energy sentiment to price moves and outlines how investors can reconcile different methods to gauge risk and value.

Alphabet set to beat the market in 2026 but unlikely to replicate 2025 surge

January 17, 2026, 3:21 PM EST. Alphabet, parent of Google, was a top performer in 2025 among the Magnificent Seven, a group of large tech names that surged last year. The unusually strong run may not repeat in 2026, but the stock could still beat the market. Key themes: Gemini, Alphabet's AI model, is winning enterprise adoption; Google Search remains a dominant cash cow, and AI-generated Overviews have helped keep traffic intact. Political risk from antitrust eased after a lighter penalty and no breakup was mandated, while Chrome and Android stay core to the business. A later monetization of AI could lift the multiple, though the near term remains uncertain. The stock hovered around $330 with a roughly $4 trillion market cap as of the latest session.

AI-generated trading signals for Ivanhoe Electric IE:CA show strong ratings; buy/sell levels published

January 17, 2026, 2:36 PM EST. AI-generated signals for Ivanhoe Electric Inc. (IE:CA) were updated on Jan 17, 2026 at 02:02 PM ET. The note, by Thomas H. Kee Jr., Editor of Stock Traders Daily, lists explicit trading plans. On the long side, buy near 21.35 with a target of 24.89 and a stop at 21.24. On the short side, sell near 24.89 with a target of 21.35 and a stop at 25.01. Ratings for near, mid and long terms appear Strong. The report flags AI-generated signals and includes a chart for IE:CA. This is a market signal update, not a formal investment advisory.

Frontier Communications Parent (FYBR) valuation check after price strength

January 17, 2026, 2:19 PM EST. Frontier Communications Parent (FYBR) trades near US$38.49 after a recent price advance. A Simply Wall St review flags a 1.6x price-to-sales (P/S) ratio, above the peer average and the US telecom sector, prompting questions about how much growth is already baked into the price. The stock has returned about 8% over the past year and roughly 34% over three years. The company posted a US$381 million net income loss, underscoring risk if the multiple compresses. A discounted cash flow (DCF) model puts fair value at about US$80.85, implying roughly 52% upside from current levels. Investors should weigh this against profitability trajectory and valuation risks as they gauge Frontier's future path.

Moog (MOG.A) Valuation Appears Fair After DCF Check, But Upside Limited

January 17, 2026, 2:06 PM EST. Moog Inc. trades near $291 after a strong multi-year run, with 6.7% weekly, 19.3% over 30 days, and 292.9% over five years. A Simply Wall St valuation pack gives Moog a 3/6 value score, reflecting mixed signals from different methods. A 2-stage Discounted Cash Flow (DCF) model pegs intrinsic value at about $299.78 per share, versus the $290.80 close, implying roughly a 3% discount and a fair value stance. The model uses Free Cash Flow to Equity (FCFE), with trailing FCF around $103.6 million and forecasts to 2027 of $273.8 million; projections extend to 2035. P/E remains a quick lens on price vs. earnings, but growth and risk shift the balance. In short, Moog looks fairly valued, but near-term catalysts matter.

Medpace Holdings (MEDP) remains attractive after 81% surge, but valuation flags persist

January 17, 2026, 2:05 PM EST. Medpace Holdings (MEDP) has climbed 81% over the past year, trading near $610.90 as investors weigh growth versus risk. Over the last 7 days the stock rose 2.7% and 30 days 9.7%; year-to-date 7.0%. The 5-year return sits at ~330%, with 3-year gains of about 166%. A valuation check by Simply Wall St assigns MEDP a 1/6 score for being undervalued. The centerpiece is a Discounted Cash Flow (DCF) analysis, using a 2-stage free cash flow to equity model, which puts an intrinsic value around $731.59 per share-roughly a 16.5% discount to the $610.90 price, suggesting the stock is undervalued on this metric. The stock trades at a P/E of 39.75x, above the industry average of about 37.46x and peers at 31.90x, tempering the case for value.

ReNew Energy Global fair value pegged at US$7.95 as stock slides to US$5.38

January 17, 2026, 2:04 PM EST. ReNew Energy Global (RNW) faces renewed investor scrutiny after a 30% decline over the last 90 days and a 21% slide in the past year, with the stock around US$5.38. A recent fair-value view places the target at US$7.95, suggesting the shares are undervalued on long-term earnings. The 12-month picture shows 15.1% revenue growth but a 10.1% drop in net income, underscoring margin pressures. Bulls point to expansion of its manufacturing footprint, marquee backers such as British International Investments, and a new 4 GW TOPCon facility that could lift earnings visibility. Risks include tighter competition in project bidding and potential delays. The current P/E of about 21x sits above the 16.8x renewable-energy average, signaling valuation risk if sentiment weakens.

EVEX valuation flags a deep discount to DCF fair value after three-year slide

January 17, 2026, 2:03 PM EST. Eve Holding (EVEX) last traded at $4.52, down 38.4% over three years as interest in early-stage electric aviation ebbs and flows. Simply Wall St's valuation score is 2/6. The DCF model, using a two-stage free cash flow to equity approach, shows a latest 12-month free cash flow loss of $182.843 million, with forecasts turning positive by 2030. Discounting those cash flows yields an intrinsic value around $27.06 per share, implying the stock is undervalued by about 83% versus the market price. The analysis also notes how P/B can be used with non-profitable firms, though its guidance is less clear for EVEX until earnings turn positive. Traders weigh the gap between price and cash-flow-driven value amid volatile funding for electric aviation.

CRH reassessed after share-price pullback; DCF points to modest overvaluation

January 17, 2026, 1:49 PM EST. CRH trades around $122.97 after a mixed week. The shares are down 6.4% over the last week but up about 27.2% in the past year and 196.9% over three years. Our simple valuation flags CRH at 2/6. A Discounted Cash Flow (DCF) model yields an intrinsic value of about $112.86, implying the stock is roughly 9% overvalued at current levels. The analysis notes a narrative around construction materials and infrastructure demand as a driver, while risk and return trade-offs remain in focus. The piece also explains how different valuation methods can converge on a fair value, with caveats about assumptions. Investors may want to monitor price moves and update dashboards as new data arrives.

Ramsey: The secrets of the rich aren't secrets; invest simply in what you know

January 17, 2026, 1:32 PM EST. On The Ramsey Show, Dave Ramsey argues that the so-called secrets of the rich are not secret. Wealth, he says, rests on simple, familiar bets and focusing on what you understand. He cites a $200 million rancher who concentrates on farmland to show wealth can come from expertise, not gimmicks. Ramsey warns against chasing trendy investments or following friends who lack transparency, citing Bernie Madoff as a cautionary example. He endorses the KISS principle and sticks to three core investments: his business, paid-for real estate, and mutual funds. He rejects single stocks, gold, and crypto as speculative. The approach echoes Peter Lynch's adage to buy what you know; Lynch's Magellan fund grew from $20 million to $14 billion AUM.

Two AI Stocks Set to Beat the Market in 2026: Nvidia and Meta Platforms

January 17, 2026, 1:31 PM EST. Two AI stock ideas for 2026: Nvidia and Meta Platforms. Nvidia remains the dominant supplier of AI chips, with data-center demand driving revenue. In the third quarter, Nvidia reported revenue of $57 billion, and guided to about $65 billion in the current quarter, up ~14%; adjusted operating profit rose 25%. Analysts expect earnings to grow substantially this year, supporting a forward multiple around 25x. Nvidia's Vera RubinAI platform, backed by seven chips, is expected to be deployed by major cloud providers, signaling long-term AI infrastructure growth. Meta Platforms is highlighted for its ability to convert AI investments into revenue, leveraging more than 3.5 billion daily active users across Instagram and Facebook to monetize AI-enabled features and ads. The S&P 500 rose; these names offer exposure to AI megatrends, though risks include spending cycles in data centers.

Willis Towers Watson Valuation Post-Move: Fair Value Around $369 vs $329 Close

January 17, 2026, 1:17 PM EST. Willis Towers Watson (WTW) drew fresh attention after a recent price move. The stock closed at $329.41. The one-day gain was 0.28%, with a year-to-date return of 0.96% and five-year TSR of 70.38%, suggesting longer-term momentum. A fair-value view places WTW at about $369.16 per share, implying the stock is undervalued relative to current levels. The market trades at a P/E ratio of 14.9x, above the US Insurance sector 12.8x but below the peer average of 29.5x, signaling limited further upside if earnings slip. The case rests on growth in advisory demand, recurring fee streams, and higher earnings in the mid-term, supported by disciplined costs, divestitures, and investments in high-growth regions. Risks include tougher competition, integration costs, and margin pressures.

Dunelm Group fair value trimmed; analysts split on growth and re-rating risk (LSE: DNLM)

January 17, 2026, 1:16 PM EST. Dunelm Group's fair value estimate was trimmed to £12.21 a share from £12.87 as analysts balance upbeat mid-term guidance with questions about growth durability. The revision reflects a tug-of-war in research: some banks reaffirm guidance and upgrade to Outperform, while others stay Hold or Neutral and flag uncertainty around whether the gains are fully priced in. RBC Capital lifts the target to 1,300 GBp and argues growth acceleration; Jefferies maintains Hold with a higher target, citing margin expansion and solid trading momentum. Panmure Liberum turns cautious with a downgrade; JPMorgan sticks to Neutral while nudging targets. The shift frames Dunelm's narrative around execution, margin delivery, and the scope for further re-rating. Track how these targets evolve to gauge momentum.

AI-generated signals highlight trading plan for Manulife Smart Defensive Equity ETF (CDEF:CA)

January 17, 2026, 1:15 PM EST. AI-generated signals for Manulife Smart Defensive Equity ETF (CDEF:CA) surface a cautious near-term stance. The trading plan remains long-oriented: buy near 12.00 with a stop at 11.94; no short positions are offered at this time. The accompanying ratings split across horizons: near-term strong, mid-term weak, long-term strong. The data is time-stamped Jan 17, 2026, 12:50 PM ET, and notes that updated AI-generated signals are available for review. The report, authored by Rick W. with editor Derek Curry, emphasizes checking the timestamp and caveats around AI-generated guidance. Investors should consider the long-term context of the ETF, while monitoring price action around the 12.00 level and the 11.94 stop.

Bank of Hawaii valuation: momentum tests fair value near price

January 17, 2026, 1:00 PM EST. Bank of Hawaii trades at $71.25, with an intrinsic value of about $74, implying a 44.6% discount to the stated fair value and a near-term upside of roughly 3.9%. A recent price move left the stock up 0.85% on the day, while 90-day returns of about 16.6% contrast with a 1-year total shareholder return near 4.2%. Analysts model revenue rising about 9% a year over the next three years, supported by margins that could lift earnings multiples for banks. The bear case rests on Hawaii's real estate cycle and higher funding costs that could compress net interest margins. The full narrative walks through earnings paths, valuation math, and the assumptions behind the $74 fair value. Investors can adjust the thesis with Do it your way or screen for other opportunities.

Microsoft stock faces Musk's $134 billion claim ahead of Jan. 28 earnings

January 17, 2026, 12:48 PM EST. Microsoft (MSFT) shares closed Friday at $459.86, up 0.7% but down about 3.6% for the week as Elon Musk pursues as much as $134 billion in a lawsuit alleging wrongful gains by OpenAI and Microsoft. Musk told a federal court OpenAI revenue was pegged at $65.5-$109.4 billion and Microsoft at $13.3-$25.1 billion; a jury trial is set for April. Markets will be closed for Martin Luther King Jr. Day, delaying the next session to Tuesday. The broader backdrop remains macro jitters that have weighed on megacap tech on rate and policy moves. Probes into Activision Blizzard's sales tactics were announced, and Wikimedia said it will compensate firms using Wikipedia to train AI. Microsoft also struck a carbon-credit deal with Indigo Carbon, estimated at $171-$228 million.

Tradeweb Markets: The fintech stock you'll hear about

January 17, 2026, 12:46 PM EST. Tradeweb Markets operates a global network of electronic marketplaces that underpin institutional trading across four asset classes. Unlike consumer-facing brokers, Tradeweb is not a household name, but it's become essential to the smooth functioning of financial markets. The company's platforms focus on rate-related fixed income-sovereign debt, mortgage-backed bonds, and swap contracts on rate indexes; credit-corporate and municipal bonds and credit default swaps; equity via ETFs and related options; and money markets-including certificates of deposit, money market funds, and repos. It also supplies market data to institutions. While it serves equity investors only through ETFs, it supports dealers, treasurers, and other institutional clients with faster, more transparent trading. In more than 25 years, Tradeweb has established leadership in electronic trading.

ProPetro Holding (PUMP) undervalued on DCF as shares rebound

January 17, 2026, 12:45 PM EST. ProPetro Holding Corp (PUMP) looks undervalued in a DCF check. The model assigns an intrinsic value of $134.39 per share, implying the stock is about 92.3% undervalued versus its current price. Shares rose 9.4% in the past week and 13.8% over 30 days, with a 4.8% year-to-date gain, 10.6% over 3 years and 23.8% over 5 years; the 1-year return is -5.6%. The latest twelve months show a free cash flow loss of $19.96 million; projections extend a decade, moving from a $93 million loss in 2026 to a $946.58 million loss in 2035. On a cross-check, the stock's P/S ratio is 0.83x, vs. the Energy Services industry average of 1.20x; peer group average sits higher at 1.

Definium Therapeutics (DFTX) Undervalued by DCF After 1-Year 110% Surge

January 17, 2026, 12:44 PM EST. Definium Therapeutics (DFTX) has jumped about 110% over the past year and trades around $15.05. A Simply Wall St valuation snapshot gives a 2/6 score, signalling limited undervaluation from some checks. The report applies a 2-stage Free Cash Flow to Equity (FCFE)Discounted Cash Flow (DCF) model. It projects negative FCF in the last 12 months and an eventual positive stream through 2030, yielding an intrinsic value of about $234.95 per share. Compared with the current price, that implies the stock is roughly 93.6% undervalued under this setup. The takeaway: momentum may outpace fundamentals, but the base-case relies on volatile profits and pipeline milestones. Investors should weigh the potential value against risk factors and biotech sector dynamics.

VOO vs VTI: Weighing large-cap focus against the total stock market

January 17, 2026, 12:30 PM EST. Choosing between VOO and VTI comes down to view on small-caps. VOO tracks the S&P 500-roughly 500 of the largest U.S. companies-with heavy megacap tech weightings. VTI covers those firms and more than 3,500 additional stocks across large-, mid-, and small-cap. Expense ratios are both 0.03%. Over five years, the S&P 500 averaged 14.45%, versus 13.05% for the Total Stock Market ETF, a small gap driven by tech-led gains. Recently, large-cap leadership narrowed as the cycle shifted and small caps weighed on performance. In early 2026, the S&P 500 ETF lagged the broader market year-to-date. For the long run, both are solid options; the choice hinges on whether you want small caps in your portfolio.

Two growth stocks to buy and hold for 10 years: Robinhood and HCA Healthcare

January 17, 2026, 12:29 PM EST. Investors looking a decade ahead avoid bets tied to short-term noise. The piece weighs two growth names: Robinhood Markets and HCA Healthcare as long-term holdings. Robinhood has driven revenue and earnings higher in recent years, but it faces a steep forward earnings multiple of about 46.5 and exposure to cryptocurrency trading, which can swing with crypto cycles. Still, its appeal endures: strong appeal among younger investors, a modern app, and ongoing product expansion. Initiatives such as Robinhood Legend, AI trading tools, and a growing Robinhood Gold subscription offer recurring, higher-margin revenue. The analysis suggests these drivers could support solid results through the next decade, even as valuation and crypto exposure temper the outlook. The piece emphasizes that a 10-year horizon helps manage risks and capture potential outperformance.

Andlauer Healthcare Group AND:CA – AI-generated signals and trading plans

January 17, 2026, 12:28 PM EST.AI-generated signals for Andlauer Healthcare Group Inc. Subordinate Voting Shares (AND:CA) were published Jan. 17, with an updated timestamp. The note presents two trading plans: a long entry near 51.41 with a target of 55.46 and a stop at 51.15; and a short entry near 55.46 with a target of 51.41 and a stop at 55.74. The update also lists ratings for AND:CA across Near, Mid, and Long horizons, ranging from Neutral to Strong. A chart for AND:CA accompanies the report, and readers are advised to check the data timestamp. The piece follows a market-brief cadence with concrete levels, defined risk points, and mentions AI-generated signals as decision-support.

PSLV.U:CA AI-generated signals flag near-term buy at 11.66 for Sprott Physical Silver Trust

January 17, 2026, 12:12 PM EST. AI-generated signals for PSLV.U:CA flag a near-term buy for Sprott Physical Silver Trust. Traders are advised to buy near 11.66, with a stop at 11.60. No short positions are offered at this time. The timestamp is 11:54 AM ET, January 17, 2026. Ratings by term show Near-term: Strong, Mid-term: Weak, Long-term: Neutral. The signals accompany updated materials for PSLV.U:CA and form part of an ongoing AI-driven set of recommendations. No target price is published for the longer horizon; market participants should watch the entry near the suggested level and adjust risk controls accordingly.

Amazon poised for a 2026 rebound as AWS margins and ad growth support a revival

January 17, 2026, 11:57 AM EST. Amazon's 2025 performance lagged the Magnificent Seven, but investors see a rebound in 2026. After a year when the S&P 500 rose roughly 16%, Nasdaq up over 20%, and the Dow near 13%, Amazon gained about 5% in 2025-the weakest among the group. The company has used robotics and automation to shave costs and lift efficiency; Morgan Stanley projects nearly 40 fulfillment centers with robots, potentially saving up to $4 billion. The focus shifts beyond e-commerce to AWS, which accounted for about 18% of revenue but more than 65% of operating income in Q3. Advertising remains the fastest-growing, high-margin segment, up 24% year over year, ahead of AWS (20%), third-party seller services (12%), and other lines. In short, a 2026 revival case hinges on margins, ad growth, and AWS profitability.

Blue Bird (BLBD) seen undervalued by DCF despite multi-year rally

January 17, 2026, 11:42 AM EST. Blue Bird (BLBD) trades around $49.03 after a multi-year rally. The stock has: 1.2% higher in the last week, 5.3% lower in 30 days, 4.9% higher year to date, and 19.7% over the past year. A Discounted Cash Flow model yields an intrinsic value of about $93.51 per share, implying the price is undervalued by about 47.6%. The model uses a 2-stage Free Cash Flow to Equity approach; latest twelve-month FCF is about $158.8 million, with forecasts ranging from $40.3 million in 2026 to $222.9 million in 2035. It also notes a valuation score of 6/6. In summary, the stock's current price sits well below the cash-flow-based fair value, suggesting upside if growth and capital-goods sentiment improve.

Five TSX Stocks to Hold for the Next Decade

January 17, 2026, 11:30 AM EST. The Motley Fool Canada argues five TSX stocks offer durable franchises for the next decade. RBC anchors Canadian portfolios. As the country's largest bank, it benefits from scale, diversification and steady dividend growth, though its P/E trades near 2010 levels, suggesting a pullback entry may be prudent. CNQ stands out in a resilient energy mix, with long-life reserves and disciplined capital allocation; it pays about a 5.3% dividend and traded around $44.62 at writing, roughly 15% below consensus target. BIP.UN owns inflation-linked cash flows across utilities, pipelines and data centres, with a roughly 5.0% yield and a 14% discount to fair value. BAM leans on an asset-light model in alternative assets, positioning for long-term growth as investors lean into real assets. The fifth stock isn't named in the excerpt.

Uber vs Coca-Cola: Which Stock Looks Best to Buy Now

January 17, 2026, 11:28 AM EST. Both Uber and Coca-Cola posted double-digit gains in 2025. Uber, with a roughly $177 billion market cap, surged about 35% in the year and expanded its ecosystem through ride-hailing and delivery, supported by group bookings of $25.1 billion in Q3 (the gross value of orders) and a 25% year-over-year rise in delivery bookings. The company notes only about 15% of U.S. adults use Uber, leaving room for cross-selling and adoption, plus a growing ad business with a run rate near $1.5 billion. Coca-Cola, a far older and more stable franchise, dominates beverages with 200+ brands and 2.2 billion daily servings; it delivered 16% total return in 2025, underscoring its durability. Investors face a tradeoff: growth potential at Uber versus defensive cash flow at Coca-Cola. Choice depends on risk tolerance and time horizon.

Buffett indicator at record high as S&P 500 climbs in 2026

January 17, 2026, 11:27 AM EST. The S&P 500 has risen about 21% in the past 12 months and roughly 41% from its April low last year. A popular gauge, the Buffett indicator-the ratio of U.S. stock market capitalization to GDP-sits around 222%, a level last seen before the 2021 bear market. No metric is perfect, and a recession or bear market is not guaranteed. Still, the reading could warn investors to exercise caution. Prepare portfolios by focusing on solid, long-term growth companies, and consider trimming or exiting weak stocks while prices surge. In short, preparation matters more than precise timing as downturns arrive unpredictably.

TSMC's AI-chip dominance keeps stock appealing at $1.8 trillion market cap

January 17, 2026, 11:26 AM EST. TSMC sits among a handful of companies with a market cap above $1 trillion, now near $1.8 trillion after a 2025 rally. The stock's strength tracks demand for AI chips and a shift to HPC-the high-performance computing segment that now dominates its revenue. In Q3 2025, HPC brought in about $18.87 billion, more than the total in 2021. TSMC operates as a foundry, producing chips for clients like Apple rather than selling designs. Even if AI demand cools, the mix spans smartphones, computers, cars and more, supporting a durable core. The article argues the valuation is high but the fundamentals justify a buy stance for patient investors.

Hitachi Construction Machinery (TSE:6305) appears undervalued after a strong run, according to a DCF that suggests ~28% upside

January 17, 2026, 11:25 AM EST. Hitachi Construction Machinery closed at ¥5,421 after a 7.8% weekly rise, with a 1-year return of 59.6%. Over 3 years and 5 years, the stock is up about 105.6% and 100.6%, deepening valuation questions. Simply Wall St uses a 6-point framework and gives the stock 5/6 on valuation. A two-stage Free Cash Flow to Equity model puts the intrinsic value at about ¥7,553 per share, implying roughly 28.2% upside to today's price. In short, the stock looks undervalued on this DCF view. DCF, or discounted cash flow, projects future cash flows and discounts them to present value. Investors will watch for shifts in project pipelines and balance sheets that could re-rate the shares toward intrinsic value.

DHT.UN:AI-generated trading signals for DRI Healthcare Trust (DHT.UN:CA)

January 17, 2026, 11:10 AM EST. AI-generated signals for DHT.UN:CA (DRI Healthcare Trust) were published Jan 17, 2026. The plan lays out a long-term trading approach: buy near 15.59 with a target of 16.54 and a stop at 15.51. A short setup sits at 16.54, with a target of 15.59 and a stop at 16.62. Ratings for the term structure show near-term: Weak; mid-term: Neutral; long-term: Strong. The report notes the data come from an AI model and includes the timestamp. This is a trading signal, not a guarantee; investors should cross-check with other analysis.

AI-generated signals for CCOE:CA show buy near 16.23; Near/Mid strong, Long neutral

January 17, 2026, 10:58 AM EST. AI-generated signals for the Harvest Cameco Enhanced High Income Shares ETF, ticker CCOE:CA, were updated Jan 17, 2026. The plan lists a buy near 16.23 with a stop at 16.15; no target is given. No short positions are offered. For Jan 17, the Near and Mid terms are rated Strong, while the Long term is Neutral. The data originate from an AI-generated system and are published by Bill T., contributor, under Editor Derek Curry. Note the timestamp and that the signals reflect AI guidance. The ETF's chart page shows the current signal status for CCOE:CA.

Bank of America names five stocks to buy ahead of earnings, including Amazon

January 17, 2026, 10:57 AM EST. Bank of America named five stocks it sees as best positioned heading into earnings, including Amazon. The bank points to AWS revenue growth and AI catalysts as upside drivers, arguing Amazon could see multiple expansion as it scales AI and retail efficiency. Other buy-rated names highlighted by CNBC Pro include Brookdale Senior Living, Carvana, Corning, and Vertiv. Analyst Joanna Gajuk upgraded Brookdale to Buy, citing improving occupancy and 15%+ adj. EBITDA growth with limited exposure to government payors; Brookdale reports in late February and has risen ~13% this year. For Carvana, a higher price target reflects TAM expansion; Corning benefits from a balanced glass market and AI-driven demand; Vertiv should gain from margin recovery and AI-adoption in data centers.

Ashtrom Group trades well above modeled value after multi-year gains

January 17, 2026, 10:56 AM EST. Is Ashtrom Group (TASE:ASHG) priced attractively? At about ₪80.14, the stock's multi-year gains shadow the valuation case. Simply Wall St assigns a valuation score of 1/6, a signal the stock may be richer than fundamentals. The Dividend Discount Model (DDM) yields an intrinsic value of about ₪8.54 per share, meaning the current price sits roughly eight times that value and marks the stock as overvalued. The model assumes a payout of about 34%, ROE of 5.09%, and a long-term dividend growth input around 3.16%. In short, investors are weighing price against fundamentals as the market prices in growth and risk. The full valuation breakdown may surface additional red flags and peer context.

Centuri Holdings (CTRI) Valuation in Focus After Momentum: P/S vs. DCF Signals

January 17, 2026, 10:55 AM EST. Centuri Holdings (CTRI) has drawn buyers after a rally, with shares at $27.80 and a 90-day return of 38.24%. The stock trades at about 1x price-to-sales, above the estimated fair P/S of 0.8x and below the wider US Construction industry average of 1.3x, signaling cautious pricing. A one-year total return of 27.17% underscores momentum, but fundamentals remain thin: net income of $2.514 million on $2.841 billion revenue. A near-term risk is that the shares trade above the $25.50 analyst target. A DCF model suggests a fair value around $16.82, implying the stock is overvalued on that basis. Investors should weigh growth forecasts around 8.5% and insider ownership against valuation signals and market sentiment.

Dollar Tree may be overvalued after 94% rally, DCF analysis shows

January 17, 2026, 10:44 AM EST.Dollar Tree (DLTR) closed at $139.95, after a 94% rally over the last year. The stock has chalked up 5.7% in the past week, 9.0% in 30 days, and 9.6% year-to-date, with a three-year decline of about 5.3% and a five-year gain near 29.7%. Simply Wall St. assigns a 0/6 score on its valuation checks, flagging questions about value. The firm uses a 2-stage Free Cash Flow to Equity (DCF) model; latest twelve-month FCF is about $1.44 billion. The model yields an intrinsic value of about $110.81 per share, implying the price is roughly 26.3% above fair value and the stock is overvalued relative to this estimate.

Morningstar stock looks overvalued after 34% year-long drop, per Excess Returns model

January 17, 2026, 10:42 AM EST. Morningstar's shares hover around US$213.91 after a 34.1% retreat in the last year. An Excess Returns valuation yields an intrinsic value of about US$99.89 per share, implying the stock is roughly 114.1% overvalued at current levels. The calculation uses a Book Value of US$36.48, Stable EPS of US$6.47, an average ROE of 15.39%, and a Cost of Equity of US$3.52, with an Excess Return of US$2.95. A Stable Book Value of US$42.05 per share from two analysts rounds out the inputs. The report notes Morningstar's recurring revenue, brand strength, and product mix, but says the price largely reflects higher growth expectations. It also flags a 3/6 on valuation checks and mentions P/E as a quick earnings proxy. Investors weigh long-term potential against recent price action and risk.

Brown-Forman appears undervalued after multi-year price weakness, per DCF model

January 17, 2026, 10:40 AM EST. Brown-Forman trades at $26.40 after a 7-day gain of 1.7%, but a 30-day slide of 8.5% leaves the stock down about 20.7% over the past year. A multi-model look at value shows a disconnect between price and what the business could earn. A Discounted Cash Flow (DCF) model returns an intrinsic value near $42 per share, suggesting the shares are undervalued by roughly 37%. Simply Wall St's 6-point framework also flags the stock as undervalued (5 of 6). The analysis notes how investor expectations are shifting around brand strength, growth potential, and risk for Brown-Forman's mature spirits portfolio, helping explain why price moves have not been linear.

Elevra Lithium (ASX:ELV) rises on staged NAL debottlenecking plan to accelerate output

January 17, 2026, 10:38 AM EST. Elevra Lithium surged 6.2% after January 2026 plans for its North American Lithium (NAL) mine outlined a staged debottlenecking strategy. The company aims to accelerate permitting, lift spodumene concentrate output by about two years and phase capex while pushing lower unit operating costs. The plan prioritises low-risk brownfield debottlenecking – using existing permits and temporary mobile crushing to raise milling capacity before a full new crushing and ore-sorting circuit. Management argues the approach could sharpen near-term catalysts: progress toward the 315 ktpa target and clearer cash costs visibility. The move supports an investment narrative that links move from loss-making growth toward disciplined, lower-cost production, even as Elevra remains in transition with a new CFO and board. Analysts flag potential impacts from new cost reporting on margins. The stock reaction signals market optimism but risks remain.

Kering (ENXTPA:KER) Valuation Check After Share-Price Weakness and Mixed Returns

January 17, 2026, 10:24 AM EST.Kering (ENXTPA:KER) has faced renewed pressure as shares weaken. The luxury group's stock slid 4.21% in the latest session, with momentum fading over the past week, month and three months, though the 1-year total return remains positive at 22.07%. The valuation shows a P/E around 48.6x, near peers at about 53.8x. The market implies a Fair Value of €296.45 versus a last close of €288.70, a small gap. Analysts' targets range from €135.0 to €360.0, with a consensus near €200.65. Risks include revenue declines across key brands and ongoing store closures, which could pressure margins. A roughly 2.6% undervaluation signal persists, modest in the face of the earnings multiple.

Stephens trims Global Payments target to $90 as outlook turns cautious for GPN

January 17, 2026, 10:23 AM EST. Stephens cut Global Payments' price target from $95 to $90, citing a cautious outlook. The firm keeps an equal weight rating, with a target implying about a 21.92% upside from Friday's close. Analysts are mixed. Cowenhold; TD Cowen trims to $90 and holds; Citigroup lifts to strong buy; Jefferies drops to $75 with a hold; KeyCorp moves to sector weight from overweight. MarketBeat shows three Strong Buy, seven Buy, fifteen Hold, one Sell; consensus target $98.62. The stock opened at $73.82 and is down about 1.6%. Market cap about $17.5B; P/E 10.37, PEG 0.63, beta 0.79. One-year range $65.93-$114.17. Q3 EPS $3.26 on $2.43B revenue; FY25 guidance $6.60-$6.66; current-year EPS $11.89. Insider Connie D. Mcdaniel sold 4,464 shares at $77.81.

Recursion Pharmaceuticals (RXRX) seen undervalued after DCF signals amid price weakness

January 17, 2026, 10:13 AM EST.Recursion Pharmaceuticals (RXRX) closed at $4.67 as shares show weakness. Over the last 7 days the stock rose 0.2%, and in the past 30 days it fell 0.2%, with a 11.2% year-to-date gain but a 28.5% drop over the last year. The market weighs its development model against traditional checks. A two-stage Free Cash Flow to Equity model yields an intrinsic value of about $9.31 per share, suggesting the stock is roughly undervalued at current prices. The analysis also considers P/B (price-to-book), noting that P/B reflects growth expectations and risk. Investors are reassessing whether the current price fairly reflects Recursion's prospects as discussions of its drug-discovery approach continue.

PNC.B: AI Signals Show Weak Ratings; Trading Plans Define Tight Entry/Exit Levels

January 17, 2026, 10:12 AM EST. On January 17, 2026, AI-generated signals for Postmedia Network Canada Corp. Class NC Variable Voting Shares (PNC.B:CA) were updated. Ratings for PNC.B:CA across terms are Weak in the Near, Mid, and Long horizons. The trading plan lays out a Long entry: Buy near 0.84, target 1.01, stop loss 0.84. A Short setup: near 1.01, target 0.84, stop loss 1.02. Readers are reminded to check the timestamp; a chart is referenced. The signals stem from an AI-generated system for Postmedia Network Canada Corp. Class NC Variable Voting Shares, with the chart link noted as available.

Jacobs Solutions appears undervalued after multi-year rally, DCF implies ~40% gap

January 17, 2026, 10:11 AM EST. Jacobs Solutions trades near $139.94 a share after a strong multi-year run. It has risen 44.8% and 58.8% over the last three and five years. A Discounted Cash Flow (DCF) model, which estimates intrinsic value by discounting projected cash flows, yields about $232.87 per share, implying roughly a 39.9% undervaluation. It uses a two-stage Free Cash Flow to Equity (FCFE) projection, with 2035 FCFE around $1,622.5m. The stock trades on a P/E of 52.6x, above the Professional Services group, and the source rates the valuation 2/6. Market attention to backlog and contract visibility can drive pricing, leaving the overall case mixed.

CIBC valuation flags undervaluation after rally, says Excess Returns model

January 17, 2026, 10:10 AM EST. CIBC trades at CA$128.46 on the TSX, up 1.7% in 7 days and 47.4% over the last year. Simply Wall St flags a mixed picture: a 3/6 valuation score and an intrinsic value around CA$185.55 per share, a roughly 30.8% discount to price. The Excess Returns framework uses book value CA$67.37, stable value CA$70.09, stable EPS CA$10.18, and a cost of equity CA$5.04 to derive value. Return on equity is forecast near 14.5%. The analysis notes sector risk from capital requirements, loan quality, and higher funding costs. In short, the rally looks stretched relative to fundamentals, though the stock shows potential if earnings and capital dynamics hold.

Hewlett Packard Enterprise stock appears undervalued after pullback, DCF fair value at $34.49

January 17, 2026, 10:09 AM EST. Shares of Hewlett Packard Enterprise closed at US$21.44, down about 3.3% last week, 10.7% over the past month and 11.3% year to date. The move comes as analysts and investors monitor HPE's role as an enterprise technology provider and the sensitivity of its stock to IT spending cycles. Simply Wall St rates the stock at 6 out of 6 in its valuation checks. A two-stage Discounted Cash Flow model based on free cash flow projects a fair value of US$34.49 per share, implying the stock trades about 37.8% below intrinsic value. The piece also weighs the Price-to-Sales approach as a valuation lens, highlighting growth and risk as key drivers. The narrative suggests HPE could be undervalued given cash flow potential, though valuation depends on assumptions about future spending.

NXDT three-year returns remain weak; TSR cushions decline via dividends

January 17, 2026, 10:08 AM EST. NXDT, the NexPoint Diversified Real Estate Trust, posted a 16% gain in the latest quarter but three-year results remain weak. The shares are down about 68% over three years, while revenue has fallen about 3.5% per year and the firm has been unprofitable over the past 12 months. If growth returns, it could help, but the topline decline complicates an earnings case. Insiders have been buying over the last year, a possible sign of confidence that isn't guaranteed. For perspective, total shareholder return, or TSR (which includes reinvested dividends), fell 56% in three years — a better result than the price move thanks to distributions. In the past year, the broader market rose about 17%; NXDT lost roughly 16%.

Leerink lifts Danaher price target to $270; stock set for upside

January 17, 2026, 10:07 AM EST. Leerink Partners lifted Danaher's price target to $270 from $260 and kept an outperform rating, signaling roughly 14% upside from the prior close, the firm said. The report comes as Bank of America trimmed its target to $220, Deutsche Bank raised to $250, Argus set $265, and Goldman Sachs initiated with a Buy and $265; Robert W. Baird offered $247. MarketBeat shows a consensus Moderate Buy at about $252.83 from 21 Buy and 5 Hold ratings. Danaher opened at $236.05; the 52-week range spans $171.00 to $258.23. Key metrics cited include a high P/E around 48.7 and a market cap near $167 billion. Q3 earnings were $1.89 per share on revenue of $6.05 billion, beating estimates; margin stood at 14.44%. An insider sold 5,174 shares for roughly $1.09 million.

Brace for a stock-market pullback: practical steps to weather a crash

January 17, 2026, 9:57 AM EST. Investors are warned that a market crash is not a question of if but when. Analysts say 30% sell-offs occur roughly every decade in both the TSX and S&P 500; 40% declines are rarer, and halving the market has happened only twice this century, around dot-com and the 2008 crisis. Amid chatter that 2026 could bring a repricing of AI gains, advisers urge calm. The guiding rules: use dollar-cost averaging to deploy a fixed amount at regular intervals; stay invested to avoid locking in losses; treat downturns as a fire-sale buying opportunity rather than a reason to panic. The Buffett reference underscores the idea: market dips let you buy America's future at lower prices. The article stresses discipline and regular contributions to endure the cycle.

Dongjiang Environmental forecasts deeper 2025 loss as industry restructures

January 17, 2026, 9:56 AM EST. Dongjiang Environmental expects a deeper net loss for 2025, guiding RMB1.05-1.35 billion, versus about RMB804 million in the prior year, with basic loss per share of RMB0.95-1.22. Management pins the deterioration on fierce competition and margin compression in core non-hazardous treatment and recycling businesses, plus asset and credit impairment provisions. A sustainable earnings rebound will take time as the group presses a strategic shift toward technology-driven resource recycling, utilization and integrated environmental services. The latest analyst takeaway is a Hold with a HK$2.00 price target. Dongjiang is a PRC-incorporated environmental services company listed in Hong Kong, operating in hazardous and non-hazardous waste treatment and aiming to build a full renewable-resource recycling chain.

Organon (OGN) undervalued after price weakness; DCF signals about 88% upside

January 17, 2026, 9:54 AM EST.Organon (OGN) trades at $8.76 after a choppy year. Its shares gained about 8.8% last week and 25.3% in the past month, but remain down 42.9% over 12 months and 67.6% over three years. On Simply Wall St's valuation checks, Organon scores 5 out of 6 for being undervalued. A two-stage Free Cash Flow to Equity (FCFE) model pins an intrinsic value of about $74.85 per share, implying roughly 88.3% upside from the current price. The latest twelve-month free cash flow is about $639 million; projections rise to $1,350 million by 2030, extending to 2035 with moderating growth. The result: a potential disconnect between price and cash flows, though investors should weigh growth, risk and the P/E framework within the broader sector context.

Banner (BANR) Valuation Signals Undervaluation as Momentum Cools

January 17, 2026, 9:53 AM EST. Banner (BANR) trades near $64.87 after a mixed momentum spell, with a 1-day decline of about 1.65% and a 30-day drop of 3.16%. Longer-term returns remain healthier, with 3-year TSR at 12.09% and 5-year TSR at 47.87%. The stock shows an indicated intrinsic discount of 44.62% and roughly a 12.28% gap to analyst price targets, prompting questions about whether the pullback reflects value or growth expectations. A bull case rests on steady revenue growth and margin expansion from digitization and new deposit and loan origination systems, potentially lifting net margins. Risks include heavy commercial real estate exposure and higher funding costs that could compress margins longer than anticipated. The analysis pegs a fair value of $73.40, suggesting the shares are undervalued, though the view hinges on earnings and cost dynamics.

NYSE to host MSCI U.S. options, expanding ICE's index-derivatives footprint

January 17, 2026, 9:52 AM EST. NYSE will become the U.S. options venue for MSCI benchmark indexes, with contracts to be listed on NYSE Arca and NYSE American, pending regulatory approval. The move deepens ICE's partnership with MSCI and extends its footprint in index-linked derivatives, complementing ICE's large share of MSCI futures volumes and risk-management tools. Analysts will assess whether U.S.-listed MSCI options materially shift ICE's longer-term growth narrative or mainly reinforce near-term drivers in mortgage-technology integration and fee competition across core trading franchises. ICE's plan to invest up to US$2 billion in Polymarket signals a broader push into digital and prediction-market infrastructure, which could support electronification and data-driven catalysts, but adds regulatory and technology risk. Valuation views remain split, with some seeing upside from index derivatives and others cautious on cyclical energy and commodities exposure.

AstraZeneca Still Sensibly Priced After 31.3% One-Year Gain, DCF Indicates Undervaluation

January 17, 2026, 9:51 AM EST. AZN, AstraZeneca (LSE:AZN), closed at £140.52, down 1.2% in the past week, up 3.7% over 30 days, 3.4% year to date and 31.3% over 12 months. With a broad portfolio and ongoing pipeline, the stock stays in focus as regulatory decisions and milestones shape risk. Simply Wall St assigns a 3/6 valuation score. The piece stresses DCF as a valuation lens: a two-stage Free Cash Flow to Equity model puts an intrinsic value around $253.49 per share, versus the current price, implying roughly a 44.6% discount and an undervalued reading on cash flows. A secondary check uses the P/E framework, noting how growth and risk influence what is "normal."

Robinhood now lists 50 cryptocurrencies for U.S. investors; Bitcoin, Ethereum, Solana among top picks

January 17, 2026, 9:38 AM EST. Robinhood now lists 50 cryptocurrencies for U.S. investors, up from a limited set in the past. The expansion aligns with looser state scrutiny and broader platform policy, though some assets remain restricted in New York or Texas. The roster includes Bitcoin (BTC), Ethereum (ETH), and Solana (SOL) among the most liquid choices, with others ranging from Chainlink (LINK) to Polkadot (DOT) and several niche tokens. The author favors the larger, well-known coins with clearer investment theses. The piece notes that the three best of the bunch are Bitcoin (BTC), Ethereum (ETH), and Solana (SOL), reflecting long-standing market presence and liquidity.

Alight, Inc. slumps 26% in 30 days as revenue headwinds weigh on valuation

January 17, 2026, 9:37 AM EST. Alight, Inc. shares fell 26% in the last 30 days, extending a 12-month decline of about 77%. The stock trades at a P/S ratio near 0.4x, far below the Professional Services group where peers trade above 1.3x. The weak multiple follows shrinking revenue: a 1.9% drop last year and a 25% slide over three years. Six analysts forecast revenue turning negative again, about −0.2% next year, versus industry growth near +6.3%. The P/S gap hints at downside risk if top line does not rebound. While some investors still consider the stock attractively priced, there is no clear floor yet. Market participants will watch upcoming results and whether analysts lift forecasts as revenue trends stabilize.

Brazil stocks shrug off Venezuela attack as inflation cools and rate cuts loom

January 17, 2026, 9:36 AM EST. Brazil's Bovespa rose nearly 1% on Jan. 5 and has climbed about 3% through Friday, as investors shrug off the Venezuela attack. The iShares MSCI Brazil ETF (EWZ) has gained around 3% since the event. Domestic drivers matter: inflation slowed to 4.26% in December, below the 4.5% target, and unemployment sits near a record low. The Selic rate remains at 15% after tightening, with markets eyeing possible rate cuts. Analysts warn easing could clash with a wide fiscal gap, but may attract more foreign money. Traders say the market is pricing inflation relief and policy normalization rather than geopolitics.

Ackman's 39.5% Bet: Amazon, Alphabet and Uber Dominate Pershing Square Portfolio

January 17, 2026, 9:22 AM EST. Pershing Square Capital Management's stock mix centers on three large holdings. Bill Ackman's fund counts Amazon, Alphabet, and Uber Technologies among its largest bets, together making up about 39.5% of the portfolio. A portfolio is the fund's collection of investments. Amazon accounts for roughly 8.7% of the portfolio, spanning e-commerce, cloud, and ads; its prime growth engine is AWS, the cloud unit, and its pursuit of efficiency via automation. Alphabet accounts for about 10.5%, retaining leadership in search while expanding AI features. Uber sits among the top positions, reflecting a bet on ride-hailing and delivery networks. The concentration underscores Ackman's emphasis on large, cash-generating platforms; investors will weigh the risk of a narrow slice of holdings amid macro swings.

Three stocks could soar 40%+ in 2026: Dream Finders Homes, EPR Properties, SoFi Technologies

January 17, 2026, 9:21 AM EST. Three stocks could soar 40% or more in 2026, per a market view tied to rate projections for 2026. The S&P 500 remains near an all-time high, yet opportunities persist. The piece cautions there is no crystal ball for short-term moves, and the outlook depends on market conditions and 2026 rate projections. The stocks highlighted are Dream Finders Homes, EPR Properties, and SoFi Technologies. Prices cited are the morning quotes of Jan. 9, 2026, and the video publication was Jan. 10, 2026. The author discloses holdings in the three names; the disclosure also notes the publisher's positions. The report uses plain language, with brief jargon notes such as CFP (certified financial planner).

Secret formula to ease retirement anxiety as data show bear markets are rarer

January 17, 2026, 9:20 AM EST. Wall Street stress tests for retirees often overstate risk. Ben Carlson of Ritholtz Wealth Management finds bear markets and 40% drawdowns are rarer than headlines imply. Using data back to 1928, a 30% market drop appears in about 10% of years; a 40% drop in about 5%. For a 65-year-old who lives to 85, the odds of a 40% drawdown in that window are small, and portfolio losses can be muted by prudent asset allocation. For example, with a 50% stock exposure, a 40% market decline could trim the nest egg by about 20%, while the rest remains in fixed income such as bonds and treasuries. The piece offers a simple formula to ease retirement anxiety, grounded in the low probability of a catastrophic crash.

Nova (NVMI) valuation under scrutiny after rally

January 17, 2026, 9:08 AM EST. Nova's shares sit at US$445.70 after a run of gains that has driven multi-year returns higher. Seven-day, 30-day and YTD performance are strong, with 1-, 3-, and 5-year gains accelerating investor attention. Valuation checks from Simply Wall St place Nova at a 1/6 value score. In valuation models, the DCF approach, using a 2-stage Free Cash Flow to Equity method, pegs an intrinsic value of $83.32 per share, versus the current price, suggesting the stock is overvalued by about 435%. The P/E stands at 53.94x, above the industry average of 43.37x but below the peer average of 72.44x, implying the stock trades at a premium to the sector yet not far from peers. Overall, rally has challenged traditional value math.

Powell Industries (POWL) Appears Overvalued After Rally, DCF Indicates

January 17, 2026, 9:07 AM EST. Powell Industries (POWL) trades around $419.98 after a sharp rally. In the past week it rose 14.9%, 30 days 32.4%, and it is up 19.1% year-to-date and 61.5% over the last year. Simply Wall St's valuation checklist scores the stock 2/6 for undervaluation. The piece explains a Discounted Cash Flow (DCF) model using a 2-stage Free Cash Flow to Equity approach: latest twelve-month FCF about $155 million, forecast to 2026 of $116.8 million, with projections into 2035 in the $100 million range. The model yields an intrinsic value of about $131.05 per share. At current levels, the price implies roughly a 220% premium to fair value, i.e., the stock appears overvalued. Valuation is only one lens; investors should weigh growth, margins, and macro factors.

NOVONIX valuation tested after Panasonic timing shift to 2027 mass production

January 17, 2026, 9:06 AM EST.NOVONIX (ASX: NVX), updated on its partnership with Panasonic Energy, pushing mass production of synthetic graphite anode material to the second half of 2027, while targeting industrial-grade output this year. The update follows a sharp one-day share drop of 15.84% and a 7-day decline of 24.78%, despite 1-year TSR (total shareholder return) of 37.04% and 5-year TSR of 84.77%. The stock trades at a P/S ratio of 41.3x, well above peers at 4.6x and the broader electronics sector at 1.9x. By contrast, fair-value estimates imply a P/S near 105.7x, hinting at a premium priced for future growth if sentiment shifts. Risks include a 2027 production delay and annual losses of A$66.25 million, which could pressure funding and sentiment.

Stem, Inc. shares jump 29% as revenue slump weighs on valuation (NYSE: STEM)

January 17, 2026, 9:05 AM EST. Stem, Inc. shares have risen 29% in the past month, lifting the year-to-date gain but leaving the company with weak revenue momentum. The stock's P/S ratio sits at 1x, well below many Electrical peers where P/S trades above 2x and some above 6x. Revenue declined 36% in the last year and 37% over three years, per the latest filings. Analysts forecast near-zero growth next year, vs industry growth near 12%. The modest P/S appears to reflect muted growth expectations and sentiment rather than a pure valuation metric. Investors remain cautious about Stem's path to revenue acceleration.

Comfort Systems USA jumps 27% in 30 days as high P/E reflects growth bets

January 17, 2026, 8:52 AM EST. Comfort Systems USA Inc. (NYSE: FIX) has extended its rally, up 27% in the last 30 days and 122% year to date. The stock trades at a P/E of 47.1x, well above the US market's typical levels, prompting questions about its valuation. The high multiple is framed by stronger earnings momentum, with EPS rising about 80% last year and 276% over three years. Eight analysts see EPS growing around 25% next year, versus about 16% for the broader market. Investors appear to price in continued earnings strength, even as the elevated P/E attracts scrutiny. The takeaway: the stock's valuation rests on growth expectations, and a pullback would hinge on a disappointment in the forecast.

Uber's ROCE stabilizes as profitability returns fuel reinvestment

January 17, 2026, 8:51 AM EST. Uber Technologies posted a trailing ROCE of 9.1% for the twelve months to September 2025, roughly in line with the Transportation sector's 9.7% average. The metric uses EBIT divided by (total assets minus current liabilities). The company has moved from loss-making five years ago to profitability, and 129% more capital employed is now being deployed, signaling reinvestment opportunities that could lift returns. Shares have risen about 56% over five years as investors recognize the shift. But the piece flags two warning signs to monitor and notes analysts' forward views are mixed. A detailed analyst report is suggested for Uber. This analysis reflects historical data from Simply Wall St.

Institutional owners hold 71% of Goldman Sachs; Vanguard leads with 9.1% stake

January 17, 2026, 8:50 AM EST. Institutional ownership in Goldman Sachs Group, Inc. (NYSE:GS) remains dominant, with institutions controlling 71% of the shares. The largest single holder is The Vanguard Group, Inc., with a 9.1% stake, followed by the second and third-largest holders at about 7.3% and 6.1%. The top 25 investors together own less than half, pointing to a broad base of smaller holders and no single owner with a majority. Institutions can sway trading and sentiment, given their capital and cross-portfolio influence. Investors should note earnings history and forecasts as analysts offer a range of views. The ownership profile implies meaningful influence from institutions, with potential volatility tied to shifts in institutional sentiment.

General Dynamics' 22% CAGR outpaced earnings growth over the same five-year period

January 17, 2026, 8:34 AM EST. General Dynamics (NYSE: GD) posted a five-year rally of 140%, with an 11% gain in the last three months. Over the same span, EPS grew 7.1% per year, slower than the roughly 19% annual share price advance, suggesting the market priced in improving momentum. Five-year TSR reached about 168%, driven largely by dividends; one-year TSR was 40% including dividends. The five-year annualized TSR sits around 22%. The evidence points to positive sentiment, even as earnings growth trails the price run. Investors may want to review insider activity and the role of the dividends in total returns.

Apple insiders sold $23 million in shares, signaling hesitancy

January 17, 2026, 8:33 AM EST. Apple Inc. insiders, including executives and board members, sold about $23 million of stock over the past year. The largest move was Arthur Levinson selling about $21 million at $232, below the current $256, signaling caution about valuation. The sale accounted for ~2.1% of Levinson's stake. In the last three months, insider Chris Kondo sold $1.0 million, with no reported purchases. Insider ownership sits around $2.5 billion, roughly 0.07% of the company, a sign of significant ownership but modest relative to the market. No insider buys were recorded in the past year, underscoring a cautious posture as Apple grows profits.

Is Robinhood Stock a Buy Now? Bear Market Risks and Valuation

January 17, 2026, 8:17 AM EST. Robinhood shares have fallen about 20% from their all-time high, entering a bear-market mood for the discount broker. Is this a buying opportunity or a trap? Robinhood (HOOD) competes with Charles Schwab and Interactive Brokers as a low-cost, app-driven platform that popularized commission-free trading. It expanded into crypto and recently sports betting, aiming at a younger user base. The stock trades at a lofty P/Emultiple near 50, richer than Schwab's ~24 and Interactive Brokers' ~34, and well above the S&P500 around 31. A broader market lens shows the contrast: the VanguardFinancialsETF trades around 19x earnings. The stock has surged about 1,100% over the last three years, but its customer base has never endured a deep bear market. Investors will weigh valuation against cyclicality and scale.

Analysts keep Wells Fargo forecast steady after mixed full-year results

January 17, 2026, 8:16 AM EST. Wells Fargo & Company (WFC) shares fell 7.9% to $88.38 in the week after the full-year results. Revenue came in at about US$80b, just shy of estimates; statutory EPS was US$6.26. Looking ahead, 19 analysts project 2026 revenue of US$88.6b, about 11% above the prior year, with EPS seen at US$6.99, up around 6.6%. Before the print, forecasts were US$88.4b and US$7.05 for 2026, and analysts left their view largely unchanged. The consensus price target sits at US$100; a range of US$83-US$113 shows divergent views but a cluster around the target. Analysts see growth of about 11% annualized to end-2026, versus 1.8% over the past five years and peers near 8.9%.

Labcorp declares $0.72 dividend; yield ~1.1% (LH)

January 17, 2026, 8:04 AM EST. Labcorp Holdings Inc. (NYSE: LH) will pay a quarterly dividend of $0.72 per share on March 12. The annualized dividend yield is about 1.1% at the current price, below the industry average. The company has a short dividend history-four years-with payments broadly stable. Next year, EPS is forecast to rise about 67.3%, implying a payout ratio around 21% if the trend continues, a level viewed as sustainable. Earnings growth has averaged roughly 3.5% over the last five years, but the dividend track record is not long, so investors should be cautious about relying on dividend income. The outlook hinges on future earnings and payout decisions; two warning signs have been flagged by some analyses.

ATI stock appears overvalued on DCF despite 1-year rally

January 17, 2026, 8:03 AM EST. ATI closed at $124.35, up 117.5% over the last year. A two-stage free cash flow to equity (FCF) model yields an intrinsic value of about $110.94 per share, suggesting the stock is roughly 12% overvalued on a cash-flow basis. The shares trade at a forward P/E of 37.98x, below the Aerospace & Defense industry average of about 42x, offering some valuation cushion despite the rally. Simply Wall St assigns a 2/6 valuation score. The model uses cash flow projections through 2035, with TTM FCF near $446.7 million and longer-term estimates over $900 million. The update underscores ATI's specialty materials and engineered products business and sector demand for advanced alloys. Investors should weigh the DCF signal against growth prospects and market momentum.

Abivax rally driven by pipeline attention; DCF flags overvaluation

January 17, 2026, 8:02 AM EST.Abivax SA rose on stronger biotech-pipeline attention, but a DCF framework flags overvaluation. The stock closed at €102.20, up 3.2% in 7 days and 8.1% in 30 days, with a year-to-date drop of 11.1%. Over the last year and three years the shares have surged as investors priced pipeline potential. Simply Wall St assigns ABVX a valuation score of 0/6. The analysis uses a 2-stage Free Cash Flow to Equity model; the latest twelve-month FCF was a loss of €171.7 million, with forecasts of €18.4 million in 2027. The intrinsic value per share is €31.59, implying the price is about 223% above fair value. Verdict: overvalued on this framework, even as pipeline visibility sustains attention.

Wells Fargo earnings: analysts keep forecasts after mixed full-year results

January 17, 2026, 8:01 AM EST. Wells Fargo & Company posted a mixed full-year report that sent shares down about 7.9% to $88.38 over the week. Revenue was $80 billion, with statutory earnings of $6.26 a share, broadly in line with estimates. Analysts expect 2026 revenue of $88.6 billion, up 11% from 2025, and EPS of $6.99, a 6.6% rise. Prior forecasts had been $88.4 billion and $7.05 per share, suggesting no major shift in outlook after the results. The street kept a $100 price target, with a range from $83 to $113. Growth is expected to accelerate for the bank, to about 11% revenue growth by end-2026, versus roughly 1.8% annualized over the past five years and about 9% for peers. Overall sentiment remains largely unchanged.

Pfizer's ROE underperforms peers as market weighs growth prospects

January 17, 2026, 7:52 AM EST. Pfizer's stock has risen about 4.7% in three months, but a muted ROE (return on equity) raises questions about earnings growth. The trailing-twelve-month ROE is 11% (US$9.8 billion net profit on US$93 billion of equity). That compares with an industry average ROE of 22%. Over five years, Pfizer's net income has fallen about 13%, while the industry grew about 8.6%. The company also has a payout ratio near 88% of profits, leaving roughly 12% to reinvest in growth. Investors should ask whether the market has fully priced in any future earnings expansion; without stronger capital allocation or higher retention, upside may be limited. While vaccines and a pipeline could support value, the near-term path hinges on profitability and efficiency.

Oversold Energy Stocks With RSI Near 30 Eye Near-Term Upside

January 17, 2026, 7:51 AM EST. Three energy names sit with RSI readings below 30, a classic sign of oversold conditions that traders weigh for near-term moves. Delek US Holdings (DK) has had its target trimmed to $38 after JP Morgan's Zach Parham kept a Neutral stance; the shares slipped about 3.8% on Thursday after a 9% slide in the last month and a 52-week low near $11.02. Expand Energy (EXE) remained a Buy with a target cut to $150 from UBS's Josh Silverstein; the stock fell about 1.9% to $99.52, down roughly 7% in a month, trading near a 52-week low of $91.02. XCF Global (SAFX) filed for a large share offering, leaving the stock down about 65% in the past month though it rose 2.8% to $0.14; RSI stood at 21.4.

Financial stocks slide on credit-card rate cap proposal; some see buying opportunity

January 17, 2026, 7:50 AM EST. Financial stocks dipped on news of a proposed one-year, 10% cap on credit-card interest rates, sparking risk-off moves in lenders. Major card issuers fell: Bank of America down about 4.5% week after the proposal; JPMorgan Chase off 6.6%; American Express down 6.8%; Capital One -9.9%; Citigroup -4.8%. Visa shed about 8% and Mastercard nearly 7% as networks declined alongside issuers. The S&P 500 rose earlier in the week but eased, underscoring the gap between headlines and broad markets. Past attempts to cap card rates have stalled in Congress; analysts say a move is unlikely to pass soon, limiting downside risk if the bill remains non-passable. Still, some traders see the sell-off as temporary, with a potential buying opportunity for select financial names if sentiment stabilizes.

Regal Rexnord at US$160: valuation signals limited upside

January 17, 2026, 7:49 AM EST. Regal Rexnord Corp (NYSE: RRX) shares have climbed about 24% over the past two months, trading near its 52-week high. Our valuation puts the stock roughly at fair value, about 8.5% below an estimated intrinsic value of $174.92, implying limited upside if the market has already priced in positives. The name exhibits a high beta, signaling greater price swings than the broader market and possible pullbacks to create a buying opportunity. Next-year earnings are projected to grow about 85%, supporting stronger cash flows but not guaranteeing gains in the stock price. Investors should also weigh the balance sheet and management track record. With the stock around fair value, a deeper dive is warranted before buying on dips rather than chasing near-term gains.

FIGR stock rally triggers valuation questions after sharp surge

January 17, 2026, 7:48 AM EST. Figure Technology Solutions, ticker FIGR, traded near US$73.91 after a sharp rally. The stock rose 27.3% in the past week, 98.2% in 30 days and 69% year to date, fueling questions about upside and risk. Simply Wall St rates its valuation 0/6. Its Excess Returns model estimates an intrinsic value of US$15.17 per share, implying the shares are about 387% above that value and categorizing the stock as overvalued. The firm also notes a Discounted Cash Flow framework and a P/S ratio as additional lenses, especially for companies still building earnings. With market sentiment shifting toward diversified financials, investors should rely on multiple valuation checks rather than a single metric.

Galiano Gold climbs 5.1% after securing US$75 million revolving credit facility

January 17, 2026, 7:47 AM EST. On December 17, 2025, Galiano Gold said its Asanko Gold Mine subsidiary secured a new US$75 million revolving credit facility to support operations in Ghana and bolster liquidity. The facility offers flexibility to fund working capital and future mine development without immediate equity issuance. The liquidity could underpin the next phase of development and finance the Abore drilling program, with about US$3.1 million allocated toward deeper drilling toward a maiden underground resource in the MRMR. Still, the company cautions that returns remain exposed to concentration in a single asset and rising Ghanaian royalties and levies. Forecasts show US$612.9 million revenue and US$157.4 million earnings by 2028. fair value estimates range widely, including a CA$4.80 per-share value implying roughly 23% upside; investors should consider multiple perspectives.

Ampco-Pittsburgh (AP) shares up 118% in 12 months amid mixed earnings and notable insider buying

January 17, 2026, 7:46 AM EST.AP's stock has surged 118% over the past year and 178% in the latest quarter, lifting the three-year TSR to about 82% even as the company posted negative EPS last year. Revenue was broadly flat, suggesting price gains may reflect other factors and market sentiment more than pure earnings growth. The year also featured notable insider buying in the most recent quarter, a potential positive signal. However, the five-year annualized TSR remains negative, around -3%, underscoring a mixed longer-term picture. Investors should weigh earnings quality, cash flow, and risk factors alongside the near-term price move before drawing conclusions about the stock.

Ford Stock Outlook 2026-2030: Earnings Beat, Dividend Yield at 4.41%

January 17, 2026, 7:45 AM EST. Ford Motor Company, traded as F, posted a Q3 2025 earnings beat with EPS of 0.45 and revenue of $47.19 billion, but trimmed full-year guidance after a fire at a major aluminum supplier. The stock has slipped 0.51% in the last month after a 6.13% gain in the prior month, and is up about 38.6% over the past year. It has risen roughly 57% from its one year low on April 8. Ford continues to reward shareholders with a dividend yielding about 4.41% (15 cents per share quarterly). Looking ahead, the debate centers on whether Ford's core ICE lineup and the F-Series can sustain growth amid macro headwinds, supply-chain risk, and evolving auto demand. Analysts offer varied 12-month projections.

Waste Management posts 107% five-year TSR as shares track EPS growth

January 17, 2026, 7:36 AM EST. Waste Management (NYSE:WM) has produced a 107% total shareholder return (TSR) over five years, beating the 59% price-only market gain. The five-year share-price rise stands at about 92%, though the more recent period has been softer, with a 6.1% TSR in the last year. Over the same horizon, earnings per share grew about 12% annually, roughly tracking the 14% annualized price gain, suggesting sentiment hasn't drastically shifted. Insider buying picked up in the last three months, a potential positive signal. The company has delivered an average annual TSR of 16% over five years, underscoring a strong long-run track record, even as near-term pace slows while the growth strategy unfolds.

US stock markets closed for MLK Day 2026; Nasdaq and NYSE reopen Jan. 20

January 17, 2026, 7:35 AM EST. US stock markets will be closed on Monday, Jan. 19, 2026, in observance of MLK Day. The Nasdaq and NYSE will not trade and will reopen with regular hours on Jan. 20. The U.S. bond markets will also be closed on Jan. 19 and reopen Jan. 20, per the Securities Industry and Financial Markets Association. After MLK Day, markets resume normal activity until Presidents Day on Feb. 16. The 2026 holiday schedule also lists other market holidays, including Good Friday (Apr. 3), Memorial Day (May 25), Juneteenth (Jun. 19), Independence Day (Jul. 3), Labor Day (Sept. 7), Thanksgiving (Nov. 26) with early close on Nov. 25, and Christmas (Dec. 25) with early close on Dec. 24.

Vista Gold Corp. AI-generated signals point to long entry near 1.18, stop at 1.17

January 17, 2026, 7:33 AM EST. Vista Gold Corp. shares trade as VGZ:CA with AI-generated signals updated January 17, 2026. The plan for the stock in the long horizon is to buy near 1.18 CAD, with a stop loss at 1.17 to cap downside. No short positions are offered at this time. Ratings for Near, Mid and Long terms appear as Strong, Neutral, and Strong respectively. The note cites a timestamp and author, framing this as a data-driven briefing rather than a price target. A stop loss is a preset price to limit losses; readers should treat it as part of a risk-management framework.

Pacira BioSciences shares fall 28% in a rough month as P/S signals muted growth

January 17, 2026, 7:32 AM EST. Pacira BioSciences Inc. (PCRX) has lost about 28% of its share value over the past month, with a 14% decline in the last year for long-time holders. The stock trades at a price-to-sales (P/S) ratio of 1.1x, well below many US pharmaceutical peers, where P/S often exceeds 4.7x and can top 25x. The low multiple reflects softer revenue growth recently. In the last fiscal year, revenue rose 3.1%; over three years, revenue is up about 9.6%. Six analysts project roughly 8.4% annual revenue growth over the next three years, a pace well short of the industry's ~33% growth. Investors price in limited upside, and the P/S remains muted amid modest top-line momentum.

Tredegar (TG) adds US$27 million to market cap in the past week as five-year struggles persist

January 17, 2026, 7:31 AM EST.Tredegar Corporation (NYSE: TG) added about US$27 million of market value in the past seven days, yet five-year losses cloud the stock narrative. The shares rose about 14% in the latest quarter, but are down roughly 47% over five years, underperforming the market. Total shareholder return (TSR) over five years registered a loss of 41% after dividends. A more recent glide, TSR up about 4.5% over the trailing 12 months, edges above zero but trails the market. Revenue has declined about 7.5% annually; profitability has returned in the last five years, a sign of stabilization perhaps. Investors watch for a rebound, but one warning from analysts remains. Insider buying could provide a spark, if it materializes.

Unifi's debt burden vs. market cap raises dilution risk

January 17, 2026, 7:30 AM EST. Unifi, Inc. (NYSE: UFI) carries debt that may test its balance sheet. As of September 2025, net debt stood at about US$88.6 million, down from US$122.9 million a year earlier, with cash of US$20.6 million. The latest balance sheet shows liabilities of US$65.0 million due within a year and US$118.5 million beyond that, against US$20.6 million in cash and US$83.8 million in near-term receivables. That leaves liabilities about US$79.2 million higher than liquid assets, a gap larger than the company's market capitalization of roughly US$72.2 million. Management may face pressure to raise capital if a quick balance-sheet cleanup is needed, potentially causing dilution for shareholders. Over the past year, revenue declined to US$560 million, and EBIT (earnings before interest and taxes) slipped into a loss.

Procter & Gamble appears undervalued after cash-flow analysis despite share-price weakness

January 17, 2026, 7:14 AM EST. Procter & Gamble traded at $144.53, up 1.9% over 7 days but weaker over 30 days and 1 year. A cash-flow focus points to a value opportunity. A Discounted Cash Flow (DCF) analysis pegs the stock's intrinsic value at about $193.88 per share, implying shares are roughly 25.5% undervalued relative to today's price. The model uses a two-stage Free Cash Flow to Equity framework, anchored by a forward view to 2035 and a latest twelve-month FCF of about $15.4 billion. The piece also flags the P/E ratio as a secondary measure for this mature consumer-staples name, noting growth and earnings risk shape the normal multiple. The stock has logged a -7.9% 12-month return and earns a 4 of 6 value score in the checks.

SpaceX IPO Could Raise Over $30 Billion, But Analysts Warn of Risks

January 17, 2026, 7:13 AM EST. SpaceX aims for a 2026 IPO that could raise more than $30 billion, potentially the largest in history, though the company has yet to file. The plan hinges on its dominance in launch services, Starlink satellite internet and reusable rocket tech, with critics noting the lack of public comparables. Private valuation could hinge on bets for orbital data centers and AI compute, per ARK Invest's Daniel Maguire, who points to SpaceX's decade lead and full reusability as differentiators versus Blue Origin. Veteran IPO scholar Jay Ritter cautions that traditional IPOs skew toward institutional buyers, and that valuation, timing and execution risk could affect returns. Investors should weigh SpaceX's multi-domain growth against a distant, uncertain path to liquidity.

Fairfax Financial slips below 50-day moving average as analysts adjust targets

January 17, 2026, 7:02 AM EST. Fairfax Financial Holdings Limited (TSE:FFH) edged below its 50-day moving average on Friday, trading as low as C$2,436.42 against the line of C$2,463.78. The shares last traded at C$2,436.42 on volume of 119,835. Analysts updated targets across the Street: Raymond James trimmed to C$2,900 from C$3,050; National Bankshares lifted to C$3,200 with an Outperform rating; BMO Capital Markets cut to C$2,600; Scotiabank raised to C$3,050 with an Outperform. MarketBeat shows five Buy ratings and one Hold, with a consensus price of C$2,764.29. Fairfax's market value sits near C$53.91 billion, with a P/E of 11.80 and a P/E/G of 0.27. The company reported C$52.04 EPS and C$17.72 billion revenue in the quarter, with a net margin of 13.90% and ROE of 17.43%.

AI-generated signals show near-term strength for SFI:CA amid no long plans

January 17, 2026, 7:01 AM EST. Solution Financial Inc. (SFI:CA) is in focus as AI-generated signals update January 17. The report shows no long plans at this time. A short near 0.28 is indicated, with a stop-loss at 0.28 and no target provided. The near-term rating is Strong, with mid- and long-term readings listed as Neutral. The update notes a timestamp and points readers to the AI-generated signals page. A chart for SFI:CA accompanies the note, underscoring that the data reflect sentiment rather than guaranteed moves. Readers should treat this as a snapshot of AI-driven guidance rather than a sole basis for trading decisions.

Sarepta Therapeutics looks undervalued after 82% annual drop, supported by a DCF valuation

January 17, 2026, 7:00 AM EST. Shares of Sarepta Therapeutics (SRPT) traded around $21.13 as the year-long decline deepened. The stock is down 11.3% over the past week and 82.1% over 12 months, with only a muted 30-day move. A Simply Wall St valuation review flags DCF as a key driver, showing an intrinsic value of $75.74 per share and a view that the stock is undervalued by about 72% at current prices. The model uses a 2-stage free cash flow to equity approach; the latest twelve-month FCF is a loss of $360.01 million, but projections turn positive to $273.50 million in 2026 and $506 million in 2027, reaching $466 million by 2030. The firm scores 5/6 on valuation checks, underscoring a potential base case for longer-term investors.

Talen Energy: Is TLN Still Attractively Valued After a 58% One-Year Rally?

January 17, 2026, 6:59 AM EST. TLN closed at $371.66, up 0.2% last week, 5.6% in 30 days, -6.3% YTD, and 58.2% over the past year. The stock carries a valuation score of 3/6. A two-stage DCF shows a latest twelve months' free cash flow of about $162.7 million and forecasts $2.532 billion in 2030, with a rise from $1.134 billion in 2026. Discounting to today yields an intrinsic value near $1,281.16 per share, about 71% below the price, implying the stock is undervalued on that model. The P/E ratio is 75.13x, well above the Renewable Energy industry average of 16.94x and higher than peers. Investors weigh the upside implied by the DCF against the high multiple and broader risks.

Is Viasat (VSAT) Still Attractive After a 417% One-Year Surge

January 17, 2026, 6:58 AM EST. Viasat closed at $45.94, up 416.8% in the past year, with 7-day and 30-day gains and a 22.1% YTD rise. The rally coincides with broader attention on satellite connectivity in the US tech sector. Simply Wall St rates VSAT 5/6 for undervaluation. The piece walks through valuation methods: a DCF model using a 2-stage Free Cash Flow to Equity framework yields an intrinsic value of about $117.88 per share and suggests the stock is about 61% undervalued. It also uses a P/S approach for cross-checking. The aim is to align cash-flow prospects with the current price.

Valero Energy: 85% institutional ownership; top 15 hold 51% of shares (NYSE:VLO)

January 17, 2026, 6:43 AM EST. Valero Energy Corp's share register shows 85% institutional ownership, illustrating the influence of professional buyers on NYSE:VLO. The top 15 holders control 51% of shares, with the Vanguard Group largest at about 12%, then roughly 8.5% and 5.9% for the next two. Hedge funds have little presence. With institutions owning a large stake, trading swings by these funds can move the stock, creating a potential crowded trade risk if sentiment shifts. No single holder has a majority. The story also notes analyst coverage and recent insider activity; investors will weigh earnings and revenue trends alongside continued institutional appetite as Valero's growth profile unfolds.

Ryanair valuation check after strong 12-month run and price cooldown

January 17, 2026, 6:29 AM EST. Ryanair Holdings (ISE:RYA) trades at a P/E of 12.8x after a robust 12-month total return of about 60.6%, even as near-term momentum cooled. The shares closed around €28.80, down about 0.6% on the day and with a 2.2% decline over the past month. Over three months the stock rose roughly 14.5%; revenue stands at about €15.1b with net income near €2.4b. Relative to peers, the Irish market average of 14x supports a 12.8x value, but the global airlines average of 9.2x makes the multiple look rich versus international peers. The valuation hints at upside if earnings hold, yet risks from weaker travel demand and cost pressures could squeeze the premium.

Reddit (RDDT) Posts Rising ROCE as Profitability Returns and Reinvestment Accelerates

January 17, 2026, 6:28 AM EST. Reddit has moved into profitability, reporting a trailing return on capital employed (ROCE) of 9.9% for the year to September 2025, above the industry average of 6.9%. ROCE measures a company's pre-tax profit relative to the capital it uses; calculated as EBIT ÷ (Total assets − Current liabilities). The company is deploying 72% more capital than a year ago, signaling reinvestment to sustain growth. The stock has delivered about 32% total return over the past year. While absolute ROCE remains modest, the trend points to improving efficiency as profits return. Readers should assess the current price against the intrinsic value estimate before drawing conclusions.

Is a stock market crash imminent in 2026? 155 years of history weigh in

January 17, 2026, 6:27 AM EST. Long-run stock returns remain unmatched by other assets, but the near-term outlook hinges on valuation. The piece flags the CAPE ratio, or Shiller P/E, as the best historical gauge of market risk. Since 1871, the S&P 500's Shiller P/E has averaged about 17.33. Valuation has climbed in recent years, contributing to investor caution about a pullback even as equities have advanced. Under President Trump, the Dow Jones Industrial Average rose about 57% in his first term, the S&P 500 gained 70%, and the Nasdaq surged 142%; 2025 brought further gains of roughly 13%, 16%, and 20% respectively. Yet the article cautions that no data point reliably predicts short-term moves, and a second-term pullback could be a historical echo rather than a sure outcome.

Prediction-market boom as traders quit day jobs to bet on current events

January 17, 2026, 6:15 AM EST. NPR reports Logan Sudeith, 25, quit his job as a financial risk analyst to trade full-time on prediction markets such as Kalshi and Polymarket. He clocks about 100 hours a week and says last month he earned roughly $100,000. He works from his Atlanta apartment and even DoorDashes meals to save time. His biggest wins include bets on Time Magazine's Person of the Year ($40,236), the most-searched person on Google last year ($11,083), and the New York City mayoral race ($7,448). He notes he follows public figures, including Trump, and would vote for candidates friendlier to prediction markets. The piece frames a broader boom as millions log on to place high-stakes bets on real-time events.

Daqo New Energy Could Be Undervalued After Swings, DCF Indicates

January 17, 2026, 6:14 AM EST. Daqo New Energy (DQ) trades around $25.18 after a 32% gain over the past year, but has fallen 21.2% in 30 days and 15.1% year to date. The moves reflect shifting sentiment in polysilicon-linked names and broader solar demand. Simply Wall St assigns DQ a valuation score of 4/6. A two-stage Discounted Cash Flow (DCF) model pegs the intrinsic value at $117.31 per share, implying a 78.5% discount to the current price. The model rests on trailing free cash flow of about $511.1 million, with 2027 cash flow near $104.6 million and 2035 around $1.2 billion, all brought to present value. In addition, investors watch the price-to-sales (P/S) multiple as a check on growth versus risk.

Deep Yellow names Greg Field as CEO ahead of Tumas decisions

January 17, 2026, 6:13 AM EST.Deep Yellow confirms Greg Field to start as Managing Director and CEO on 2 February 2026; Acting CEO Craig Barnes returns to CFO. The accelerated timing signals board prioritizes experienced leadership as the company nears decisions on the Tumas uranium project in Namibia. Field's early appointment aims to sharpen execution around Tumas while uranium prices and financing terms remain key swing factors. Near-term catalysts include Final Investment Decision for Tumas, additional approvals, and potential moves on Mulga Rock or M&A. Main risks remain execution, funding, and a gap between Deep Yellow's ambitions and current revenue. The leadership change is framed as a risk-management move to improve delivery, not a material shift in strategy. Shares have risen but valuation remains a point of debate among analysts.

Telix BiPASS Phase 3 US dosing with Illuccix and Gozellix; valuation signals

January 17, 2026, 6:12 AM EST. Telix Pharmaceuticals dosed the first U.S. patient in its BiPASS Phase 3 trial, testing Illuccix and Gozellix with MRI to refine biopsy decisions in initial prostate cancer diagnosis. The milestone comes as the stock trades around A$11.48, after a one-day gain of 2.96% and a 7-day gain of 2.14%, but a 90-day drop of 31.05% and a 1-year loss of 56.83%. A target near A$25.14 implies about 60% upside; a DCF fair value around A$28.87 per share suggests a similar discount to that framework. The stock's P/S ratio at 3.9x sits well below peers (~22x) and the industry average (16x), offering potential value amid execution risks across programs.

Rio Tinto (LSE:RIO) Momentum Persists Amid Mixed Valuation Signals

January 17, 2026, 6:11 AM EST.Rio Tinto Group (LSE:RIO) traded at £63.47, posting a 1-month return of 10.32% and a 1-year total return of 33.70%. An internal model signals a 25% intrinsic discount, while a fair-value narrative shows £57.09, implying the stock is overvalued. The Street's consensus target sits at £51.49, with targets ranging from £41.00 to £66.68. On valuation alone, the P/E 13.4x sits well below a rough fair ratio 29.2x and below metals peers' averages. Risks include geopolitics and regulatory hurdles around the Oyu Tolgoi project and higher leverage tied to expansion in new metals. Momentum exists, but it coexists with mixed signals on fair value and risk.

Macquarie's fixed-rate hike tests margin resilience ahead of FY2026 results

January 17, 2026, 6:01 AM EST. Macquarie Group raised fixed home loan rates by 0.25 percentage points across all terms, citing higher funding costs and evolving Reserve Bank policy expectations. The move supports near-term margins in Banking and Financial Services but could temper new lending demand. It comes ahead of the February operational briefing and the May 8, 2026 full-year results, where investors will look for signs that margin strength can withstand competitive pressure. The narrative frames earnings recovery around its diversified mix, including asset management, and exposure to commodities and global markets. The company's forecast in the narrative points to about A$20.2 billion in revenue and A$4.9 billion in earnings by 2028; some markets place a fair value around A$224.87 per share with upside estimates around 6%, though views vary across analysts and sites.

Almonty Industries stock crosses above 50-day moving average

January 17, 2026, 5:59 AM EST. Almonty Industries Inc. (TSE:AII) moved above its 50-day moving average on Friday, with the 50-day MA at C$10.77 and a high of C$12.54. It last traded at C$12.09 on 847,207 shares. The 200-day MA stands at C$8.61. The company shows a debt-to-equity ratio of 225.11, a current ratio of 0.38 and a quick ratio of 0.11, with a C$3.10 billion market cap and a negative P/E of -36.64; beta is 1.27. In the latest quarter (Nov 3), it posted EPS of C$0.19 on C$8.70 million revenue, a net margin of -58.44% and ROE of -37.52%. Analysts forecast 0.0199773 EPS for the year.

Is It Time to Reassess MAIN After Price Strength? Mixed Valuation Signals for Main Street Capital

January 17, 2026, 5:55 AM EST.Main Street Capital (MAIN) closed near US$63.96, after a 4.5% weekly gain. It is up 5.7% in the last month and 14.4% over the past year, with a strong five-year surge. The lender finances lower-middle-market companies and operates as a business development company, a structure that colors valuation and distributions. Simply Wall St scores it 3 of 6 on a valuation checklist. The article compares two approaches. Approach 1, Excess Returns, pegs an intrinsic value at about US$59.98 and finds the stock about 6.6% overvalued versus the current price, labeled ABOUT RIGHT. Approach 2 uses a P/E yardstick to relate earnings to dividends and reinvestment. The piece outlines how these signals, not a single metric, shape a take on current risk and upside.

Santana Minerals rises on deep Rise and Shine step-out drill; NZ permit expands footprint

January 17, 2026, 5:43 AM EST. Santana Minerals rose about 10.2% after a deep step-out at the Rise and Shine deposit: 38.6 metres at 1.70 g/t gold, extending high-grade mineralisation roughly 135 metres beyond prior drilling. The result sits about 465 metres past the current Mineral Resource estimate and accompanies a new 135 km² prospecting application in New Zealand, expanding the exploration footprint. The finding strengthens the case for a larger, deeper mineralised system and supports a longer-term outlook, while near-term catalysts remain: Fast-track Approvals in NZ, securing financing for the A$277 million capex, and an updated resource model. The main risks? Permitting outcomes, cost inflation versus PFS assumptions, and execution risk in a bigger footprint. Investor sentiment is positive but valuation remains debated amid ongoing drilling and funding considerations.

TLX.AX Telix Pharmaceuticals eyes Jan. 20 earnings as BiPASS readouts loom

January 17, 2026, 5:42 AM EST. TLX.AX traded at A$11.48 on the ASX ahead of its Jan. 20, 2026 earnings release. Volume was 3.58 million as investors weigh revenue growth, R&D spend, and cash flow after clinical updates. The stock is down about 55% year on year, but clinical milestones and regulatory steps could swing the valuation. In focus: near-term guidance, geographic revenue, margin progress, and any NDA/BLA resubmission updates for pipeline assets. The BiPASS Phase 3 news-Illuccix/Gozellix for pre-biopsy prostate diagnosis-could widen the addressable market if successful, boosting US uptake. Valuation: market cap A$3.89B; P/E 382.7; P/S 3.28; P/B 9.17. Key risks: trial setbacks, reimbursement delays, and radiopharmaceutical kit costs.

Markets: Cocoa prices rise as Asian grindings undershoot; West Africa harvests and ICCO outlook support futures

January 17, 2026, 5:39 AM EST. March ICE NY cocoa rose 2.22% and March ICE London 1.70% on short covering after Asian grindings fell less than expected. Q4 Asian grindings were down 4.8% y/y to 197,022 MT, versus ideas of a larger drop; North American grindings rose 0.3% to 103,117 MT. Nigeria's November exports fell 7% to 35,203 MT, with 2025/26 production seen 11% lower at 305,000 MT. West Africa's harvest outlook improved; Ivory Coast pod counts run above the five-year average as the harvest begins. Ivory Coast shipped 1.13 MMT Oct-Jan, down 2.6% y/y. ICE cocoa stocks in US ports slipped to 1,626,105 bags on Dec 26, later rising to about 1.68 million. ICCO trimmed 2024/25 global surplus to 49,000 MT and production to 4.69 MMT.

TD stock crosses above 200-day moving average; price near C$131 as analysts lift targets

January 17, 2026, 5:24 AM EST. Toronto-Dominion Bank's stock rose above its 200-day moving average on Friday, trading as high as C$131.28 and last at C$130.55 on volume of about 6.31 million shares. The 200-day line sits at C$112.27. Analyst activity followed: RBC lifted its target to C$133 with an outperform rating; National Bankshares upgraded to outperform with a C$134 target; Barclays raised its objective to C$118 and kept an underweight stance; National Bank of Canada moved to a strong-buy; Jefferies increased to C$130. Overall, MarketBeat lists a Moderate Buy consensus and a target near C$129.17. TD trades with a market cap around C$219.15 billion, a P/E of 11.29, and a beta of about 1.03. The bank last reported Dec. 4, with EPS of C$2.18 and revenue of C$16.03 billion.

Ninety One UK Ltd Hikes Apple Stake by 348,810 Shares in Q3 13F

January 17, 2026, 5:23 AM EST. Ninety One UK Ltd boosted its Apple stake by 13.9% in Q3, per its Form 13F with the SEC, a quarterly disclosure of large U.S. stock holdings. It holds 2,849,443 Apple shares, about 1.6% of its portfolio and 16th-largest, valued at roughly $725.6 million. Other institutions added to Apple as well: McElhenny Sheffield Capital Management up 14.0% to 25,105 shares ($6.39m); Strait & Sound Wealth Management up 14.7% to 105,485 ($26.86m); Mokosak Advisory Group up 3.3% to 6,880 ($1.75m); Moody Aldrich Partners up 11.1% to 2,040 ($519k); Refined Wealth Management up 3.6% to 2,850 ($726k). Institutional ownership stands at 67.73%. Insider Chris Kondo sold 3,752 shares at $271.23 on Nov. 7, leaving 15,098 shares (about $4.10 million; 0.06%). Apple opened at $255.53; 12-month range $169.21-$288.62; market cap $3.76 trillion; P/E 34.21; beta 1.09.

Anchorage Digital Preps IPO With $200-400 Million Fundraise

January 17, 2026, 5:08 AM EST. Anchorage Digital is pursuing $200 million to $400 million in new funding as it weighs an initial public offering next year, people familiar with the matter told Bloomberg. The crypto bank, officially Anchorage Digital Bank National Association, became the United States' first federally chartered crypto bank in 2021, a status it says could help it ride forthcoming rules around stablecoins and digital-asset infrastructure. After the GENIUS Act was enacted in July, Anchorage has signaled a central role in stablecoin issuance and related services. Chief executive Nathan McCauley has said the firm plans to double its stablecoin team over the next year to meet rising demand from banks, fintechs and global institutions. A company spokesperson described 2025 as a year of scale, citing acquisitions, partnerships and the launch of stablecoin issuance.

Artisan Partners APAM appears fairly valued after recent gains, intrinsic value near $47.41

January 17, 2026, 5:07 AM EST. Artisan Partners Asset Management trades around $44.31 after a 6.5% gain in 30 days and 12.2% over the past year. A valuation framework-the Excess Returns model-pegs an intrinsic value of about $47.41 per share. Inputs include a Book Value of $5.71, Stable EPS of $2.54, ROE of 53.69%, and a Cost of Equity of $0.39 per share, yielding an Excess Return of $2.15 and a Stable Book Value of $4.73. The model's intrinsic value implies the stock trades about 6.5% below that level, i.e., slightly cheap rather than deeply mispriced. Investors should monitor the inputs and track the Excess Returns signal as conditions in asset management evolve.

InterDigital (IDCC) at $308.76; DCF suggests 336% premium and overvaluation

January 17, 2026, 4:52 AM EST. InterDigital (IDCC) traded at $308.76, with a -0.1% move over 7 days, and an 81.7% surge in the last year. A two-stage Discounted Cash Flow model yields an intrinsic value of about $70.77 per share, implying the stock is overvalued by roughly 336% at current levels. The analysis notes the standalone valuation check score of 4 out of 6, and the full-year FCF run of $599.8 million, with estimates through 2027 and beyond used to project cash flows to 2035. The ten-year projection anchors to FCF between about $149 million and $301 million. The piece discusses P/E as a simple link between price and earnings, but emphasizes growth assumptions and peers when judging value.

Wabtec (WAB) Reevaluation After Multi-Year Rally as DCF Flags Overvaluation

January 17, 2026, 4:51 AM EST. Simply Wall St's take on Westinghouse Air Brake Technologies (WAB) shows the stock at $229.60, with recent moves of 2.3% over 7 days and 14.4% over 1 year. The shares have surged over 5 years, roughly 193.6%, amid rail-equipment demand and sector regulatory chatter. In its valuation check, WAB scores 0/6. The firm uses a 2-stage FCFE (free cash flow to equity) model; current trailing free cash flow is about $1.28 billion, with a 2035 forecast of $2.18 billion. Discounting those back yields an intrinsic value of $178.40 per share, suggesting the stock trades at about a 28.7% premium and may be meaningfully overvalued. The conclusion: the market appears pricing in more growth than the base case supports, guiding cautious reassessment.

DOJ probe into Powell overshadows rally as Trump pressures for rate cuts

January 17, 2026, 4:35 AM EST. U.S. equities begin the week with a rally for a third straight year as AI, quantum computing and lower-rate hopes buoy sentiment. By year-end, the Dow is up about 13%, the S&P 500 around 16%, and the Nasdaq about 20%. But the market faces a real risk: the Fed. The DOJ has opened a criminal probe into Powell over a $2.5 billion HQ renovation, while President Trump has pressed for cheaper credit and lower rates. Powell says policy must reflect the best assessment for the public, not political wishes, and the FOMC-the 12-person body that sets policy-has slowed its easing because inflation, especially shelter costs, remains persistent. The clash highlights how inflation dynamics and political pressure could reshape how markets price risk.

Greencoat UK Wind (LON: UKW) slips below 200-day moving average

January 17, 2026, 4:34 AM EST. Greencoat UK Wind PLC (LON: UKW) traded as low as GBX 98.55, dipping below its 200-day moving average of GBX 107.98 on Friday. The shares last ticked at GBX 98.85 with volume of 3,020,617. The firm carries a market cap of about £2.13 billion and a P/E ratio of -15.23, with a beta of 0.24. Liquidity signals show a current ratio of 0.09 and a quick ratio of 14.31, while debt-to-equity stands at 49.27. The stock's 50-day SMA is GBX 98.58 and the 200-day SMA is GBX 107.98, highlighting a shift toward weaker price momentum.

Eastern Platinum crosses above 200-day moving average; shares near C$0.49 (TSE:ELR)

January 17, 2026, 4:22 AM EST.Eastern Platinum Limited (TSE:ELR) crossed above its 200-day moving average on Friday, with the 200-day line at C$0.30 and an intraday high of C$0.50. The stock last traded at C$0.49 on volume of 332,548. Its 50-day SMA is C$0.38 and its 200-day SMA C$0.30. The company carries a market cap near C$99.71 million, a negative P/E of -4.45 and a beta of 2.17. Liquidity sits at current ratio 0.64, quick ratio 0.48, and debt-to-equity 0.48. In the latest quarter, the company posted EPS of -C$0.01, ROE 0.88%, and net margin 1.09% on revenue of C$19.14 million. Analysts expect current-year EPS of -0.11. The group operates PGM and chrome projects in South Africa, including Crocodile River Mine and Mareesburg.

Rotork (ROR) shares rise above 200-day moving average

January 17, 2026, 4:21 AM EST. Rotork plc (LON:ROR) moved above its 200-day moving average on Friday, trading as high as GBX 349.60, above the GBX 335.25 benchmark. The stock last traded at GBX 347 on volume 8,595,486 shares. Analysts weighed in: Panmure Gordon lifted its target to GBX 370 with a Buy rating; JPMorgan Chase raised its target to GBX 420 with an Overweight stance. Five analysts rate Buy, one Hold. MarketBeat shows a consensus price target of GBX 397 and a Moderate Buy rating. Rotork reports a quick ratio 2.16, current ratio 3.21, and debt-to-equity 1.97. Market cap about £2.86 billion, P/E around 29.66 and beta near 0.96. The board authorized a share buyback program.

Pason Systems stock crosses above 200-day moving average

January 17, 2026, 4:20 AM EST.Pason Systems Inc. shares rose above its 200-day moving average on Friday, trading as high as C$12.41 with the 200-day moving average at C$11.97. The stock last traded at C$12.28 on volume of 70,413. Analysts trimmed targets: National Bankshares lowered its target to C$15.50 with a sector-perform rating; RBC cut target to C$14.00 and kept an outperform rating. One analyst rated Buy, two rated Hold; MarketBeat pegged the consensus at Hold with a C$14.17 target. The company's market cap is about C$956.7 million, with a P/E of 15.74 and a P/E/G of 10.78; beta 0.67. Latest quarter earnings were C$0.16 per share, with revenue C$100.96 million; dividend paid Dec 31 was C$0.13, annualized C$0.52, yield 4.2%.

Secure Energy Services stock slips below 200-day moving average; targets rise

January 17, 2026, 4:19 AM EST. Secure Energy Services Inc. (TSE:SES) traded below its 200-day moving average on Friday, with a low and close near C$17.26 and a last price of C$17.71 on 429,627 shares. The 50-day and 200-day averages stand at C$17.51 and C$17.26. On the rating front, Scotiabank moved to a hold with a C$22.00 target; Raymond James raised to outperform with C$22.00; National Bankshares lifted to outperform with C$23.00; CIBC increased to C$19.00; Stifel Nicolaus to buy with C$23.50. MarketBeat shows an average Moderate Buy and a C$20.44 target. Fundamentals: debt-to-equity 48.24, quick ratio 1.10, current ratio 1.13, market cap C$3.86 billion, P/E 36.14, P/E/G 0.17, beta 0.81.

LiveRamp Valuation: Fair Value $39.63 Indicates Upside Despite Price Decline

January 17, 2026, 4:08 AM EST. LiveRamp Holdings (RAMP) has pulled back; shares about $25.07, down 2.1% today. One-year return around -22%, with a 3-year return near flat; a 1-month drop of roughly 15.8%. This analysis sets a fair value of $39.63 using an 8.4% discount rate, implying the stock is undervalued at current levels. AI-driven marketing shifts could sustain multi-year revenue growth, with LiveRamp as a neutral data-connectivity enabler across fragmented sources. Valuation remains a headwind: P/E at 41.5x vs software industry 32.4x and peer 22.9x, signaling the market prices in faster growth. Risks include revenue concentration among a few large clients and competition in data-connectivity and clean-room offerings.

Pharvaris (PHVS) DCF shows large value gap amid volatility; P/B signals mixed valuation

January 17, 2026, 4:06 AM EST. PHVS closed at $25.09 after a negative one-day move, with gains over the past month and three months but a down year. The stock shows a 30-day return of 4.15%, 90-day 18.80%, and a 1-year total shareholder return of 36.66%, signaling momentum despite a negative year-to-date move of 5.25%. The three-year TSR of 144.78% highlights shifting sentiment around its late-stage rare-disease pipeline. At a P/B of 4.5x, Pharvaris sits below peers (12.9x) but above the broader US pharma sector (2.6x), underscoring how the comparator set changes valuation. The SWS DCF model yields an intrinsic value of $298.28 per share versus the $25.09 close, implying a large valuation gap. The company remains loss-making with a net loss of €163.72m; outcomes hinge on pipeline milestones.

Nuvation Bio (NUVB) Price Swings vs. DCF-Driven Outlook

January 17, 2026, 4:05 AM EST. NUVB trades near $5.85 as investors weigh a volatile path for a biotech with no current profits. In the past week the stock slid 27.2%, and it was down 31.3% over 30 days, even as a 1-year return of 133.1% and 3-year gain of 147.9% illustrate the risk-reward in early-stage oncology names. Valuation scores show 3/6, indicating it is undervalued on roughly half of our checks. A 2-stage DCF model, using Free Cash Flow to Equity, yields an intrinsic value of about $42.40 a share, implying the price is about 86.2% below fair value. The latest twelve-month FCF was a loss of about $190.5 million, i.e., cash burn. Projections rise to $102.2 million in 2026 and $352.4 million by 2030. For profitability-less firms, P/B has limits.

Corn rises into weekend on export demand; cash and futures gain

January 17, 2026, 3:54 AM EST. Corn climbs into the weekend, with nearby cash at $3.89 1/2 and Mar 26 futures at $4.26 1/4, each up about 6 cents on Friday. The CmdtyView national average cash price rose 6 cents. Markets will be closed Monday for Martin Luther King Jr. Day. The USDA reported private export sales totaling 298,000 MT to unknown destinations, including 120,000 MT to Japan. Through Jan. 8, corn commitments stood at 52.035 MMT, about 29% above the year-ago level and roughly 64% of USDA's forecast, ahead of the 62% average pace. FAS shipment data showed 28.97 MMT shipped or shipping, about 36% of the projection. Private buyers in South Korea were cited at 130,000 MT. May 26 corn at $4.33 1/4 and Jul 26 at $4.39.

Planisware SAS ENXTPA:PLNW valuation under scrutiny as price sits below €25 fair value

January 17, 2026, 3:53 AM EST. Planisware SAS (ENXTPA:PLNW) closed at €21.50 as momentum flags fade after a recent tilt higher. The narrative fair value sits at €25.36, signaling an undervalued setup. Analysts' consensus price target is about €25.36, with a wide range from €19.0 to €29.0. At €21.50, the stock trades on a P/E of roughly 31x versus a fair 20.4x and peers' ~27.2x. Revenue growth runs at ~10.75% and net income up ~9.95%, supporting upside if contract delays ease and upselling holds. Risks include weaker new customer growth or rising costs. The narrative suggests upside potential, but the current earnings view tightens the margin for error. The full piece breaks down revenue, margins and discount-rate inputs behind the forecast.

Saia (SAIA) Valuation Signals Overvaluation After Price Slide

January 17, 2026, 3:52 AM EST. Saia (SAIA) traded at US$350.89 after a 7.0% gain in 30 days, but a 27.9% drop over the last year. The stock's valuation score stands at 2/6. A Discounted Cash Flow (DCF) analysis-projects future cash flows and discounts them to today-yields an intrinsic value of about US$124.64 per share, implying the stock is about 181.5% overvalued. The model uses a 2-stage Free Cash Flow to Equity approach; the latest twelve-month FCF is a loss of about US$95.1 million, with projections to 2029. The stock also trades at a P/E of 32.9x. In short, the price move exceeds the cautious valuation, though ongoing scrutiny of demand and pricing in the freight market remains warranted.

DaVita appears 67% undervalued by DCF as shares trade at $104.74

January 17, 2026, 3:51 AM EST. DaVita shares closed at $104.74, up 37% over the last year, as investors weigh regulatory headwinds against long-term dialysis demand. Simply Wall St's framework grades DaVita 6 of 6 on valuation, suggesting the stock may be mispriced relative to fundamentals. The analysis uses a two-stage Free Cash Flow to Equity model; DaVita's trailing twelve-month FCF runs about $1.28 billion, with a long-range projection of about $1,522.86 million in 2035. Discounting those cash flows yields an intrinsic value of roughly $323.88 per share, implying the stock is about 67.7% undervalued versus the current price. The piece notes how P/E and growth expectations shape what investors pay, amid evolving regulatory risk and demand trends.

Keyera crosses above 200-day MA; price targets mixed; dividend yield 4.8%

January 17, 2026, 3:49 AM EST. Keyera Corp. (TSE:KEY) rose above its 200-day moving average on Friday; the line stands at C$43.86 with an intraday high near C$45.33. The stock traded at C$44.99 on volume of 1.74 million. Analysts issued mixed targets: CIBC to C$57, BMO to C$51, Barclays to C$43, National Bank to C$48. MarketBeat shows a Buy consensus with a target of C$51.09. Key metrics include debt-to-equity 137.59, quick 0.57, current 1.31, market cap C$10.32B, P/E 24.06, P/E/G 1.35, beta 0.53. In the latest quarter, Keyera earned C$0.79 a share on C$1.79B revenue; ROE 16.05%, net margin 5.97%. The quarterly dividend of C$0.54 was paid Dec 31 (annualized C$2.16; yield 4.8%). Keyera operates Alberta midstream assets with gas plants and 4,000 km of pipelines.

Trump deals lift US exports to emerging markets 17%, excluding China

January 17, 2026, 3:37 AM EST. A combine harvests soybeans in Ohio as the United States moves more grain to emerging economies. U.S. soy exports to Pakistan rose in 2025, part of a broader 17% gain in shipments to emerging nations outside China. Still, gains in India and other markets only partly offset a decline in trade with an Asian rival in 2025. The data illustrate shifting demand after policy moves attributed to the Trump era. Officials and industry groups say higher sales reflect both crop harvests and targeted market access. Kentaro Takeda reports.

Corn rallies into long weekend as front-month gains offset weekly losses

January 17, 2026, 3:36 AM EST. Corn futures closed higher on Friday, with front-month contracts up 4 to 5 cents after early losses. March was down 21 cents on the week, a 4.71% drop. CmdtyView's cash price rose 6 cents to $3.89 1/2. Markets will be closed Monday for the Martin Luther King Jr. Day holiday and reopen Monday evening. CFTC data show managed money lifting its net short in corn futures and options by 65,348 contracts to 81,774-the largest new short interest since October. USDA private export sales totaled 298,000 MT to unknown destinations, including 120,000 MT to Japan, lifting weekly flash sales to 1.83 MMT. For the week, USDA export commitments stood at 52.035 MMT, 29% above a year ago and 64% of the forecast; FAS shipments were 28.97 MMT, 36% of projection. Nearby cash was $3.87 0/1; Mar 26 corn $4.24 3/4, Jul 26 corn $4.38.

HFPC.U:CA AI-Generated Signals: Short Near 2.15, Long Neutral; Near/Mid Strong

January 17, 2026, 3:32 AM EST. AI Generated Signals for Helios Fairfax Partners Corporation Subordinate Voting Shares (HFPC.U:CA) were updated January 17. The trading plan shows a Short near 2.15 with a stop at 2.16; no Long plans are offered at this time. On January 17, ratings for HFPC.U:CA are Near – Strong, Mid – Strong, Long – Neutral. The update warns readers to check the timestamp and notes the data are AI-generated. Traders should watch the chart for near-term moves as signals are recalibrated.

Canadian National Railway near fair value after DCF signals modest overvaluation

January 17, 2026, 3:21 AM EST. Canadian National Railway on the TSX traded at CA$139.28, with a 7-day return of 1.2% and a 30-day gain of 3.7%; year-to-date down 1.1%. Over 1 year, −2.8%; 3 years, −9.8%; 5 years, +13.4%. The stock faces questions on freight volumes and long-term efficiency. A valuation check from Simply Wall St scores CNR 3/6. Using a 2-stage free cash flow to equity model, the trailing FCFE is CA$3.43b. Projections reach CA$4.45b in 2029, then extend to 2035. Discounting yields an intrinsic value of CA$136.45 per share versus CA$139.28, a roughly 2.1% overvalued result and about right on this measure. Monitor freight volumes and efficiency for any re-rating.

Moog Valuation: Momentum Push, Fair Value $256.50 vs $290.80 Market Price

January 17, 2026, 3:20 AM EST. Moog (MOG.A) shows momentum after a sharp rally, trading near $290.80 with a 19% rise in the last month and about 43% over three months. A widely cited fair value is $256.50, leaving the current price above that level despite steady revenue growth. The narrative credits sustained R&D investment and acquisitions such as COTSWORKS as growth catalysts, along with operational efficiency programs that lift margins and free cash flow. Tariff headwinds and tighter working capital pose near-term risks. The stock's P/E around 41.4x sits above the implied fair value, fueling concerns the rally may outpace fundamentals. Readers should review the full narrative to gauge what the assumptions imply for earnings power into the late 2020s.

SGX stock edges higher ahead of February results; watch listings pipeline and risk sentiment

January 17, 2026, 3:18 AM EST. Singapore Exchange shares closed 0.2% higher at S$17.70 as investors await February results and signals on a beefed-up listings pipeline. The business remains driven by trading, hedging and data fees, plus earnings from listings. Even a small shift in liquidity can move results quickly. Friday's session saw about 1.28 million shares traded within a tight S$17.55-S$17.75 range. With U.S. risk sentiment volatile ahead of a holiday week, the key question is whether SGX can attract more secondary listings and how guidance will reflect a stronger listings pipeline. Analysts note potential swings in derivatives activity if volatility abates. Management has framed listings as just the start of longer-term value creation. Watch February's results and any clarity on the pace of new listings and the wider market's reaction.

Singapore Airlines (SGX:C6L) valuation hints at modest overvaluation near S$6.35 despite low P/E

January 17, 2026, 3:01 AM EST. Singapore Airlines (SGX:C6L) trades near S$6.35 after a mixed run; momentum softened. A Simply Wall St narrative puts the stock at a fair value of about S$6.17, suggesting it is roughly 3% overvalued at today's price. Analysts' consensus target sits at S$6.39, with a spread from S$5.50 to S$7.00. The current P/E of 8.8x compares with peers at ~15x and the Asia airline average of 10.3x, and is below a stated fair multiple of 13.9x. Revenue is S$19.7 billion and net income S$2.3 billion. The fair value narrative points to softer profit margins and slower revenue growth, offset by possible upside if demand holds and costs stay controlled. Key risks are outlined in the fair value narrative.

Cronos Group Shares Slip 1.7% on Friday; CRON trades near C$3.53

January 17, 2026, 2:45 AM EST. Cronos Group Inc. (TSE:CRON) fell 1.7% in mid-day trading, trading as low as C$3.52 and last at C$3.53. Volume reached 76,890 shares, well below the 164,441-share daily average. The prior close was C$3.59. Key metrics show a current ratio of 24.24, quick ratio of 24.01 and debt-to-equity of 0.17. Market cap sits near C$1.35 billion. The stock trades at a price-to-earnings ratio of 32.09, a PEG ratio of 0.12 and a beta of 1.13. The 50-day moving average is C$3.66, the 200-day moving average is C$3.44. In the latest quarter, Cronos reported C$0.07 EPS on C$50.60 million revenue; ROE was negative 4.40% and net margin −42.65%. Analysts expect current-year EPS of −0.26.

Allstate shares pull back; Excess Returns model flags strong undervaluation

January 17, 2026, 2:37 AM EST. Allstate (ALL) shares have pulled back after a breakout multi-year run. The stock has advanced 64.1% over 3 years and 96.9% over 5 years but is down 9.4% in 7 days, 8.0% in 30 days, and 5.7% year-to-date from a last close of $192.28; the 1-year return is 3.8%. The valuation check scores 6 out of 6. On Approach 1 (Excess Returns), the intrinsic value per share is about $583.45 versus the current price, implying an approximate 67% discount and signaling the stock as undervalued. The article also sketches a second approach-P/E-to frame value through earnings against price, with the broader context of risk, capital strength, and growth in the U.S. insurance sector.

UMB Financial at $122: Is the stock undervalued after price stability?

January 17, 2026, 2:36 AM EST. UMB Financial trades around $122, with modest recent gains (0.4% weekly, 2.6% monthly). The 3.6% return over the past year trails peers, even as the stock has risen about 51.2% over three years and 76.6% over five. Simply Wall St rates the stock 3 of 6 on valuation. Two models frame the debate. The Excess Returns approach yields an intrinsic value of about $243.75 a share, implying roughly 50% upside to the current price. Separately, a P/E view links multiples to growth and risk, noting that what counts as normal depends on outlook. Net takeaway: the stock appears to be undervalued according to the Excess Returns framework, though the P/E picture remains work in progress.

Compass stock seen undervalued after 90% surge; DCF implies ~12% discount

January 17, 2026, 2:35 AM EST. Compass closed at $12.86 after a 90.2% rally over the past year. It gained 22.1% in 30 days and 22.5% year to date, with a 0.2% weekly move. The company is described as a tech-driven, agent-focused real estate brokerage platform amid housing-market shifts. On valuation, Compass scores 3 of 6, signaling it is undervalued on half the metrics. A two-stage DCF yields an intrinsic value around $14.65 per share, about 12.2% above the current price. A price-to-sales check is used as a cross-check for growth and risk. The result points to a valuation gap influenced by sentiment and growth prospects in housing tech.

ICON (ICLR) undervalued after DCF signals; investors weigh long-term upside amid price weakness

January 17, 2026, 2:34 AM EST. ICON's price weakness invites a recheck of its fundamentals. A two-stage DCF model values the stock at about $238.55 a share, a 23.5% discount to the current price and an undervalued signal. The projection uses a trailing free cash flow of roughly $980.9 million and forecasts $1,180.9 million by 2030. Near term returns are muted: 0.7% over the past week, 1.8% over the past month, and an overall -7.8% in the last 12 months. Longer horizons show declines versus peers (3-year and 5-year losses). ICON remains active in contract research and clinical development, with a 4/6 value score. The takeaway, as always, depends on your risk tolerance and view of the long-term growth outlook.

Stocks finish lower as yields rise; Fed chair uncertainty weighs on markets

January 17, 2026, 2:33 AM EST. U.S. stocks closed slightly lower as yields climbed. The S&P 500 finished down 0.06%, the Dow down 0.17% and the Nasdaq-100 down 0.07%. The 10-year Treasury yield rose to about 4.23%, a 4.5-month high, as Trump signaled a hawkish Fed Chair pick, damping near-term rate-cut expectations. Early gains in chips faded as yields rose, though AI-spend optimism helped at the open. December manufacturing rose 0.2% and November was revised to +0.3%; the NAHB housing index fell to 37. Q4 earnings stay solid, with Bloomberg Intelligence forecasting S&P earnings up about 8.4% for the quarter, ex-Magnificent Seven around 4.6%. Overseas markets closed lower. The Jan 27-28 FOMC meeting is priced with roughly a 5% chance of a 25-bp cut.

Canada Goose shares fall 3.4% on Friday; trades near C$18 (TSE: GOOS)

January 17, 2026, 2:31 AM EST. Canada Goose Holdings Inc. (TSE:GOOS) shares fell 3.4% Friday, trading as low as C$17.66 and settling near C$17.91. Volume reached 352,657 shares, about 146% above the 143,324-share average. The prior close was C$18.54. Market data put the market cap at C$1.74 billion, with a P/E of 68.88, a PEG of 0.61 and a beta of 2.53. The stock trades around its 50- and 200-day moving averages at C$18.29 and C$18.22, respectively. Liquidity metrics show a quick ratio of 0.69 and a current ratio of 2.01; debt-to-equity is 168%. In the latest quarter, Canada Goose reported a loss per share of C$0.14 on revenue of C$272.6 million, with a net margin of 5.49% and ROE of 18.01%. Analysts expect approximately C$1.62 earnings per share for the year.

Nasdaq seen rising in 2026 as AI wave supports gains; Amazon highlighted as AI stock to watch

January 17, 2026, 2:30 AM EST. The Nasdaq could rise in 2026 as AI and quantum computing stay in focus. The AI market, now around $300 billion, could grow toward the trillions by decade's end. Amazon stands out as a stock with AI upside and a broad base in e-commerce and AWS. In 2025 the shares gained about 5%, supported by AI-driven efficiency in fulfillment and AWS expansion, including chips and the managed service Bedrock. AWS revenue drive helps a reported annual run rate near $132 billion. The stock trades near 30x forward earnings, a pullback from the highs of earlier years. That multiple may appeal to investors seeking exposure to AI without sky-high valuations. In sum, the Nasdaq could climb in 2026, with Amazon positioned as a measured AI play.

Ryder System shares appear overvalued after multi-year gains, valuation checks show

January 17, 2026, 2:15 AM EST.Ryder System's stock trades at US$190.74, after a 3-year gain of about 120.6% and a 1.8% drop year-to-date. Simply Wall St's valuation scores 2/6 on its 6-point checklist. The Dividend Discount Model (DDM) – which estimates value from expected dividend payments – yields an intrinsic value of US$67.57 per share. That compares with the current price, suggesting the stock is roughly 182.3% above this dividend-based estimate, i.e., overvalued. The company also trades at a price-to-earnings ratio (P/E) of 15.40x, seen as modest for a stock with growth expectations. Ryder's dividend per share is US$3.58, supported by ROE of 16.36% and a payout ratio of 27.49%. In short, valuation signals conflict with recent price action.

Sensex, Nifty end week flat as Q3 earnings hopes buoy sentiment; IT and banks lead gains

January 17, 2026, 2:14 AM EST. Indian benchmarks closed the week unchanged as investors eyed Q3 earnings and renewed India-US trade discussions, while caution persisted amid geopolitical tensions. Nifty finished the week up 0.04% at 25,694, gaining 0.11% on Friday; Sensex rose 187 points, or 0.23%, on the session to 83,570, but eased 0.01% for the week. Analysts said Q3 results, especially in IT and banks, underpin growth and demand expectations. The IT sector lifted sentiment after a bellwether guided revenue higher; banks showed improving asset quality and earnings. FIIs remained risk-averse in EMs as yields edged up. Bank Nifty closed with a bullish candlestick; RSI around 61 corroborates strength. Broader indices outperformed the benchmarks, with Nifty Midcap 100 up 0.20% and Smallcap 100 up 0.46% ahead of key global data, including US PCE and GDP prints and a tariff verdict from the US Supreme Court.

Fortuna Mining 2026 guidance nudges output higher; focus on Diamba Sud and Séguéla expansions

January 17, 2026, 1:43 AM EST. Fortuna Mining reported Q4 2025 gold-equivalent output of 65,130 ounces and full-year production of 279,207 ounces, with 2026 guidance of 281,000 to 305,000 GEO from ongoing operations after divesting San Jose and Yaramoko. The company outlined growth plans, including a potential construction decision at Diamba Sud and a feasibility review to expand the Séguéla processing plant. The update reinforces a near-term production story but keeps the main catalysts tied to these West Africa projects rather than broader asset sales. Investors face a concentrated asset base and exposure to permitting and regulatory risk in West Africa, which could cap upside if timelines slip or costs rise. The guidance signals slight volume improvement, but the key test remains execution of Diamba Sud and Séguéla and the ability to offset losses from divested assets.

Diversified Royalty Corp. (DIV:CA) AI signals prompt near-term buy plan

January 17, 2026, 1:27 AM EST. As of Jan 17, 2026, Diversified Royalty Corp. (DIV:CA) is covered by AI-generated signals. The proposed trading plan sets a buy near 3.69 and a stop loss at 3.67; no short plans are offered. The AI signal set also includes ratings by horizon: Near (Weak), Mid (Weak), and Long (Strong). The note emphasizes updating and availability of the AI-generated signals for DIV:CA. The report reflects a data-driven, cautious stance on a niche asset, with no target price provided. Traders should verify the timestamp before acting.

Rocket Lab valuation signals mixed after sharp rally; DCF flags overvaluation

January 17, 2026, 1:15 AM EST. Rocket Lab Corp. (RKLB) has surged, sparking questions about whether the current price still reflects fundamentals. The stock has posted gains of about 13.5% over a week, 78.5% in 30 days, and triple-digit returns over the past year, with a multi-year climb in the hundreds of percent. Despite the momentum, valuation checks are weak: the stock scores 0 out of 6 on the latest assessment. A DCF (discounted cash flow) model using a two-stage free cash flow to equity approach yields a fair value of $73.25 per share, suggesting the shares are roughly 31.5% overvalued at current levels. A price-to-book cross-check is referenced but not completed. Investors should weigh the momentum against the valuation gaps and the company's path to profitability.

JinkoSolar Holding: DCF signals strong undervaluation as stock rebounds

January 17, 2026, 1:13 AM EST. JinkoSolar Holding's stock closed at US$29.50, up 8.8% in seven days and 8.6% over 30 days. The rebound sits against a longer record that has declines, adding caution to the value story. Coverage notes JinkoSolar's role in the global solar supply chain and shifting sentiment toward solar names. Simply Wall St's six-point valuation checklist scores the stock 5 of 6, prompting a closer look at valuation methods. A DCF model using a two-stage Free Cash Flow to Equity framework yields an intrinsic value of US$83.25 per share, implying a roughly 64.6% discount to the current price and an undervalued read. A P/S ratio of about 0.15x sits below the semiconductor industry average, signaling potential upside if growth holds.

Colliers International Group (TSE:CIGI) stock dips 0.2% in Friday trade

January 17, 2026, 1:12 AM EST. Shares of Colliers International Group Inc. (TSE:CIGI) traded down 0.2% in mid-day Canadian trading, touching as low as C$203.17 before last price of C$204.82. Volume reached 48,516 shares, up about 6% from the 45,908-share average. The stock closed previously at C$205.24. The company posted a current ratio of 1.17, quick ratio 0.58 and debt-to-equity of 191.59. Market capitalization sits at C$10.43 billion. The stock sports a price-to-earnings multiple of 88.67 and a P/E/G ratio of 0.48, with a beta of 1.61. The 50-day and 200-day simple moving averages are C$201.75 and C$209.76, respectively. In its latest quarter, earnings per share were C$1.64 on revenue of C$2.04 billion; ROE 13.81% and net margin 3.38%. Analysts forecast current-year EPS around 9.46.

Graphic Packaging faces questions after a $21 million exit as shares fall 43%

January 17, 2026, 12:56 AM EST. Howard Capital Management Group disclosed via a January 16 SEC filing that it sold its entire stake in Graphic Packaging Holding Co (GPK), 1,069,223 shares, worth about $20.92 million. The move comes as the stock trades around $15.28 and has fallen 43.51% over the past year, lagging the S&P 500 by roughly 60 percentage points. Graphic Packaging provides fiber-based packaging for food and consumer brands. In the most recent quarter, volumes slipped 2% and sales declined 1% to $2.19 billion; adjusted EBITDA dropped 11% as pricing pressure and input costs mounted. Net leverage rose to 3.9x from 3.0x, driven by spending on the Waco facility. The combination highlights operating leverage risks if demand softens.

ADP undervalued after DCF model suggests 21% gap to price

January 17, 2026, 12:55 AM EST. Automatic Data Processing (ADP) closed at $260.44, down 2.1% in the last week and 1.9% over 30 days, with a 3.0% rise year to date. The stock is down 10.1% over 12 months, up 17.3% over three years, and 78.4% over five. A valuation score of 4 out of 6 accompanies the stock as a major payroll and human capital management provider. In a two-stage Free Cash Flow to Equity model, trailing FCF is about $4.16 billion; projected FCF in 2028 is $5.58 billion, yielding an intrinsic value of about $330.65 per share. That implies a discount of roughly 21% to the current price. A second approach using P/E is outlined, but results aren't provided in this excerpt.